Amedeo Smart

Free Medical Literature Service

 

Amedeo

Liver Diseases
  Free Subscription

Articles published in
PLoS One
    January 2021
  1. SPOGIS J, Hagen F, Thaiss WM, Hoffmann T, et al
    Sonographic findings in coronavirus disease-19 associated liver damage.
    PLoS One. 2021;16:e0244781.
    >> Share

  2. OHIRA S, Kanayama N, Wada K, Ikawa T, et al
    Improvement of image quality and assessment of respiratory motion for hepatocellular carcinoma with portal vein tumor thrombosis using contrast-enhanced four-dimensional dual-energy computed tomography.
    PLoS One. 2021;16:e0244079.
    >> Share

  3. ZHAO N, Tan H, Wang L, Han L, et al
    Palmitate induces fat accumulation via repressing FoxO1-mediated ATGL-dependent lipolysis in HepG2 hepatocytes.
    PLoS One. 2021;16:e0243938.
    >> Share

  4. SETO WK, Mandell MS
    Chronic liver disease: Global perspectives and future challenges to delivering quality health care.
    PLoS One. 2021;16:e0243607.
    >> Share

  5. YEN YH, Cheng YF, Wang JH, Lin CC, et al
    Characteristics and etiologies of hepatocellular carcinoma in patients without cirrhosis: When East meets West.
    PLoS One. 2021;16:e0244939.
    >> Share

  6. LI X, Zhong X, Wang Y, Zeng X, et al
    Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0250602.
    >> Share

  7. FERSTL PG, Filmann N, Heilgenthal EM, Schnitzbauer AA, et al
    Colonization with multidrug-resistant organisms is associated with in increased mortality in liver transplant candidates.
    PLoS One. 2021;16:e0245091.
    >> Share

  8. DA FONSECA RD, Santos PR, Monteiro MS, Fernandes LA, et al
    Parametric evaluation of impedance curve in radiofrequency ablation: A quantitative description of the asymmetry and dynamic variation of impedance in bovine ex vivo model.
    PLoS One. 2021;16:e0245145.
    >> Share

  9. FRANKOVA S, Lunova M, Gottfriedova H, Senkerikova R, et al
    Liver stiffness measured by two-dimensional shear-wave elastography predicts hepatic vein pressure gradient at high values in liver transplant candidates with advanced liver cirrhosis.
    PLoS One. 2021;16:e0244934.
    >> Share

  10. WANG F, Numata K, Takeda A, Ogushi K, et al
    Safety and efficacy study: Short-term application of radiofrequency ablation and stereotactic body radiotherapy for Barcelona Clinical Liver Cancer stage 0-B1 hepatocellular carcinoma.
    PLoS One. 2021;16:e0245076.
    >> Share

  11. CARTER JK, Bhattacharya D, Borgerding JN, Fiel MI, et al
    Modeling dysbiosis of human NASH in mice: Loss of gut microbiome diversity and overgrowth of Erysipelotrichales.
    PLoS One. 2021;16:e0244763.
    >> Share

  12. JOBIRA B, Frank DN, Silveira LJ, Pyle L, et al
    Hepatic steatosis relates to gastrointestinal microbiota changes in obese girls with polycystic ovary syndrome.
    PLoS One. 2021;16:e0245219.
    >> Share

  13. FATTAHI N, Rezaei N, Asadi-Lari M, Yousefi M, et al
    Hepatocellular carcinoma incidence at national and provincial levels in Iran from 2000 to 2016: A meta-regression analysis.
    PLoS One. 2021;16:e0245468.
    >> Share

  14. VAN AMERONGEN MJ, Vos AM, van der Woude W, Nagtegaal ID, et al
    Does perfusion computed tomography correlate to pathology in colorectal liver metastases?
    PLoS One. 2021;16:e0245764.
    >> Share

  15. CHENG K, Liu W, You J, Shah S, et al
    Safety of laparoscopic pancreaticoduodenectomy in patients with liver cirrhosis using propensity score matching.
    PLoS One. 2021;16:e0246364.
    >> Share

  16. CHO Y, Lee S, Park SJ
    Effectiveness of intraprocedural dual-phase cone-beam computed tomography in detecting hepatocellular carcinoma and improving treatment outcomes following conventional transarterial chemoembolization.
    PLoS One. 2021;16:e0245911.
    >> Share

  17. LIN X, You F, Liu H, Fang Y, et al
    Site-specific risk of colorectal neoplasms in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0245921.
    >> Share

  18. CHEN BW, Chiu GW, He YC, Huang CY, et al
    Extracellular and intracellular intermittent magnetic-fluid hyperthermia treatment of SK-Hep1 hepatocellular carcinoma cells based on magnetic nanoparticles coated with polystyrene sulfonic acid.
    PLoS One. 2021;16:e0245286.
    >> Share

  19. NIRIELLA MA, Ediriweera DS, Kasturiratne A, De Silva ST, et al
    Outcomes of NAFLD and MAFLD: Results from a community-based, prospective cohort study.
    PLoS One. 2021;16:e0245762.
    >> Share

  20. MENDOZA N, Rivas E, Rodriguez-Roisin R, Garcia T, et al
    Liver epigenome changes in patients with hepatopulmonary syndrome: A pilot study.
    PLoS One. 2021;16:e0245046.
    >> Share

  21. VOGL TJ, Riegelbauer LJ, Oppermann E, Kostantin M, et al
    Early dynamic changes in circulating tumor cells and prognostic relevance following interventional radiological treatments in patients with hepatocellular carcinoma.
    PLoS One. 2021;16:e0246527.
    >> Share

  22. SEO N, Park MS, Choi JY, Yeom JS, et al
    A prospective study on the use of ultralow-dose computed tomography with iterative reconstruction for the follow-up of patients liver and renal abscess.
    PLoS One. 2021;16:e0246532.
    >> Share

  23. ASSIS JB, Cogliati B, Esteves E, Capurro ML, et al
    Aedes aegypti mosquito saliva ameliorates acetaminophen-induced liver injury in mice.
    PLoS One. 2021;16:e0245788.
    >> Share

  24. TANAKA T, Hirooka M, Koizumi Y, Watanabe T, et al
    Development of a method for measuring spleen stiffness by transient elastography using a new device and ultrasound-fusion method.
    PLoS One. 2021;16:e0246315.
    >> Share

  25. KIM YA, Kang D, Moon H, Sinn D, et al
    Survival in untreated hepatocellular carcinoma: A national cohort study.
    PLoS One. 2021;16:e0246143.
    >> Share

  26. FUKUYAMA K, Asagiri M, Sugimoto M, Tsushima H, et al
    Gene expression profiles of liver cancer cell lines reveal two hepatocyte-like and fibroblast-like clusters.
    PLoS One. 2021;16:e0245939.
    >> Share

  27. STAHLSCHMIDT FL, Tafarel JR, Menini-Stahlschmidt CM, Baena CP, et al
    Hepatorenal index for grading liver steatosis with concomitant fibrosis.
    PLoS One. 2021;16:e0246837.
    >> Share

  28. TOMITA K, Chiba N, Ochiai S, Gunji T, et al
    Prognostic value of future liver remnant LU15 index of 99mTc-galactosyl serum albumin scintigraphy for predicting posthepatectomy liver failure.
    PLoS One. 2021;16:e0247675.
    >> Share

  29. KOVAC JD, Dakovic M, Jankovic A, Mitrovic M, et al
    The role of quantitative diffusion-weighted imaging in characterization of hypovascular liver lesions: A prospective comparison of intravoxel incoherent motion derived parameters and apparent diffusion coefficient.
    PLoS One. 2021;16:e0247301.
    >> Share

  30. KIMANYA ME, Routledge MN, Mpolya E, Ezekiel CN, et al
    Estimating the risk of aflatoxin-induced liver cancer in Tanzania based on biomarker data.
    PLoS One. 2021;16:e0247281.
    >> Share

  31. CHO WR, Wang CC, Tsai MY, Chou CK, et al
    Impact of metformin use on the recurrence of hepatocellular carcinoma after initial liver resection in diabetic patients.
    PLoS One. 2021;16:e0247231.
    >> Share

  32. POMEJ K, Scheiner B, Hartl L, Balcar L, et al
    COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospital.
    PLoS One. 2021;16:e0256544.
    >> Share

  33. SHIGESAWA T, Suda G, Kimura M, Maehara O, et al
    Baseline serum angiopoietin-2 and VEGF levels predict the deterioration of the liver functional reserve during lenvatinib treatment for hepatocellular carcinoma.
    PLoS One. 2021;16:e0247728.
    >> Share

  34. NAKADE Y, Kitano R, Sakamoto K, Kimoto S, et al
    Characteristics of bile acid composition in high fat diet-induced nonalcoholic fatty liver disease in obese diabetic rats.
    PLoS One. 2021;16:e0247303.
    >> Share

  35. TAKASE T, Toyoda T, Kobayashi N, Inoue T, et al
    Dietary iso-alpha-acids prevent acetaldehyde-induced liver injury through Nrf2-mediated gene expression.
    PLoS One. 2021;16:e0246327.
    >> Share

  36. HODEIFY R, Chakkour M, Rida R, Kreydiyyeh S, et al
    PGE2 upregulates the Na+/K+ ATPase in HepG2 cells via EP4 receptors and intracellular calcium.
    PLoS One. 2021;16:e0245400.
    >> Share

    January 2020
  37. KLEIN WM, Sonnemans LJP, Franckenberg S, Fliss B, et al
    Pseudolesion in the right parafissural liver parenchyma on CT: The base is found in embryology and collagen content.
    PLoS One. 2020;15:e0221544.
    >> Share

  38. LEE JM, Park YM, Yun JS, Ahn YB, et al
    The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study.
    PLoS One. 2020;15:e0226351.
    >> Share

  39. JUN BG, Lee WC, Jang JY, Jeong SW, et al
    Relation of fibroblast growth factor receptor 2 expression to hepatocellular carcinoma recurrence after liver resection.
    PLoS One. 2020;15:e0227440.
    >> Share

  40. LIN Y, Li H, Jin C, Wang H, et al
    The diagnostic accuracy of liver fibrosis in non-viral liver diseases using acoustic radiation force impulse elastography: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0227358.
    >> Share

  41. RAHMAN MM, Zhang C, Swe KT, Rahman MS, et al
    Disease-specific out-of-pocket healthcare expenditure in urban Bangladesh: A Bayesian analysis.
    PLoS One. 2020;15:e0227565.
    >> Share

  42. DU S, Yang JZ, Chen J, Zhou WG, et al
    Comparisons of recurrence-free survival and overall survival between microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: A multiple centers retrospective cohort study with propensity score matching.
    PLoS One. 2020;15:e0227242.
    >> Share

  43. HAUBOLD J, Ludwig JM, Li Y, Buechter M, et al
    Measuring the density of iodine depositions: Detecting an invisible residual tumor after conventional transarterial chemoembolization.
    PLoS One. 2020;15:e0227972.
    >> Share

  44. MATSUMOTO M, Yashiro H, Ogino H, Aoyama K, et al
    Acetyl-CoA carboxylase 1 and 2 inhibition ameliorates steatosis and hepatic fibrosis in a MC4R knockout murine model of nonalcoholic steatohepatitis.
    PLoS One. 2020;15:e0228212.
    >> Share

  45. RAIGANI S, Karimian N, Huang V, Zhang AM, et al
    Metabolic and lipidomic profiling of steatotic human livers during ex situ normothermic machine perfusion guides resuscitation strategies.
    PLoS One. 2020;15:e0228011.
    >> Share

  46. TSUKUDA S, Ikeura T, Ito T, Nakamaru K, et al
    Clinical implications of elevated serum interleukin-6 in IgG4-related disease.
    PLoS One. 2020;15:e0227479.
    >> Share

  47. OKAMOTO K, Koda M, Okamoto T, Onoyama T, et al
    Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease.
    PLoS One. 2020;15:e0219412.
    >> Share

  48. ARTHUIS C, Diguisto C, Lorphelin H, Dochez V, et al
    Perinatal outcomes of intrahepatic cholestasis during pregnancy: An 8-year case-control study.
    PLoS One. 2020;15:e0228213.
    >> Share

  49. YANG B, Liang J, Qu Z, Yang F, et al
    Transarterial strategies for the treatment of unresectable hepatocellular carcinoma: A systematic review.
    PLoS One. 2020;15:e0227475.
    >> Share

  50. LANZA E, Muglia R, Bolengo I, Poretti D, et al
    Survival analysis of 230 patients with unresectable hepatocellular carcinoma treated with bland transarterial embolization.
    PLoS One. 2020;15:e0227711.
    >> Share

  51. SEO JY, Lee JE, Chung GE, Shin E, et al
    A genome-wide association study on liver enzymes in Korean population.
    PLoS One. 2020;15:e0229374.
    >> Share

  52. DIAZ-RIVERA A, Meza-Rios A, Chagoya de Sanchez V, Velasco-Loyden G, et al
    Hydrodynamics-based liver transfection achieves gene silencing of CB1 using short hairpin RNA plasmid in cirrhotic rats.
    PLoS One. 2020;15:e0228729.
    >> Share

  53. VAZQUEZ C, Gonzalez ML, Ferraris A, Bandi JC, et al
    Bevacizumab for treating Hereditary Hemorrhagic Telangiectasia patients with severe hepatic involvement or refractory anemia.
    PLoS One. 2020;15:e0228486.
    >> Share

  54. DINIZ MFHS, Beleigoli AMR, Bensenor IM, Lotufo PA, et al
    Association between TSH levels within the reference range and adiposity markers at the baseline of the ELSA-Brasil study.
    PLoS One. 2020;15:e0228801.
    >> Share

  55. LIANG X, Shu W, Linyong Z, Jianshui L, et al
    Preoperative nutritional evaluation of patients with hepatic alveolar echinococcosis.
    PLoS One. 2020;15:e0229396.
    >> Share

  56. CHANG TS, Tsai YH, Lin YH, Chen CH, et al
    Limited effects of antibiotic prophylaxis in patients with Child-Pugh class A/B cirrhosis and upper gastrointestinal bleeding.
    PLoS One. 2020;15:e0229101.
    >> Share

  57. GIANNELLI G, Santoro A, Kelley RK, Gane E, et al
    Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-betaRI inhibitor galunisertib.
    PLoS One. 2020;15:e0222259.
    >> Share

  58. ZHANG J, Chen G, Zhang P, Zhang J, et al
    The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0228857.
    >> Share

  59. KELLER LM, Eighmy S, Li C, Winter L, et al
    Association of novel markers of liver disease with neonatal liver disease in premature baboons, Papio sp.
    PLoS One. 2020;15:e0228985.
    >> Share

  60. DING W, Tan Y, Qian Y, Xue W, et al
    First-line targ veted therapies of advanced hepatocellular carcinoma: A Bayesian network analysis of randomized controlled trials.
    PLoS One. 2020;15:e0229492.
    >> Share

  61. MOON AM, Jiang Y, Rogal SS, Becker J, et al
    In inpatients with cirrhosis opioid use is common and associated with length of stay and persistent use post-discharge.
    PLoS One. 2020;15:e0229497.
    >> Share

  62. LIN N, Li J, Ke Q, Xin F, et al
    Does the intermittent Pringle maneuver affect the recurrence following surgical resection for hepatocellular carcinoma? A systematic review.
    PLoS One. 2020;15:e0229870.
    >> Share

  63. CHOI J, Lee D, Shim JH, Kim KM, et al
    Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma.
    PLoS One. 2020;15:e0229696.
    >> Share

  64. WARD MD, King MA, Gabrial C, Kenefick RW, et al
    Biochemical recovery from exertional heat stroke follows a 16-day time course.
    PLoS One. 2020;15:e0229616.
    >> Share

  65. MITCHELL RA, Rathi S, Dahiya M, Zhu J, et al
    Public awareness of acetaminophen and risks of drug induced liver injury: Results of a large outpatient clinic survey.
    PLoS One. 2020;15:e0229070.
    >> Share

  66. YANG G, Zhang M, Zhao Y, Pan Y, et al
    HNF-4alpha inhibits hepatocellular carcinoma cell proliferation through mir-122-adam17 pathway.
    PLoS One. 2020;15:e0230450.
    >> Share

  67. DIEDRICH T, Kummer S, Galante A, Drolz A, et al
    Characterization of the immune cell landscape of patients with NAFLD.
    PLoS One. 2020;15:e0230307.
    >> Share

  68. YEN YH, Cheng YF, Wang JH, Lin CC, et al
    Real world clinical practice in treating advanced hepatocellular carcinoma: When East meets West.
    PLoS One. 2020;15:e0230005.
    >> Share

  69. HEINTZ MM, McRee R, Kumar R, Baldwin WS, et al
    Gender differences in diet-induced steatotic disease in Cyp2b-null mice.
    PLoS One. 2020;15:e0229896.
    >> Share

  70. USON PLS JUNIOR, Tolentino FDS, Santos VM, Rother ET, et al
    The impact of metastatic sites in advanced pancreatic adenocarcinoma, systematic review and meta-analysis of prospective randomized studies.
    PLoS One. 2020;15:e0230060.
    >> Share

  71. OKUBO H, Ando H, Ishizuka K, Kitagawa R, et al
    Carnitine insufficiency is associated with fatigue during lenvatinib treatment in patients with hepatocellular carcinoma.
    PLoS One. 2020;15:e0229772.
    >> Share

  72. THURING J, Kuhl CK, Barabasch A, Hitpass L, et al
    Signal changes in T2-weighted MRI of liver metastases under bevacizumab-A practical imaging biomarker?
    PLoS One. 2020;15:e0230553.
    >> Share

  73. RAINES MILENKOV A, Felini M, Baker E, Acharya R, et al
    Uptake of cancer screenings among a multiethnic refugee population in North Texas, 2014-2018.
    PLoS One. 2020;15:e0230675.
    >> Share

  74. LIU YW, Lin CC, Yong CC, Wang CC, et al
    Prognosis after resection of single large hepatocellular carcinoma: Results from an Asian high-volume liver surgery center.
    PLoS One. 2020;15:e0230897.
    >> Share

  75. LI S, Feng X, Cao G, Wang Q, et al
    Prognostic significance of inflammatory indices in hepatocellular carcinoma treated with transarterial chemoembolization: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0230879.
    >> Share

  76. ZHANG F, Zhu Y, Wu S, Hou G, et al
    MLK3 is a newly identified microRNA-520b target that regulates liver cancer cell migration.
    PLoS One. 2020;15:e0230716.
    >> Share

  77. MIKHAIL AS, Mauda-Havakuk M, Partanen A, Karanian JW, et al
    Liver-specific 3D sectioning molds for correlating in vivo CT and MRI with tumor histopathology in woodchucks (Marmota monax).
    PLoS One. 2020;15:e0230794.
    >> Share

  78. ABID A, Subhani F, Kayani F, Awan S, et al
    Drug induced liver injury is associated with high mortality-A study from a tertiary care hospital in Pakistan.
    PLoS One. 2020;15:e0231398.
    >> Share

  79. FUCHIGAMI A, Imai Y, Uchida Y, Uchiya H, et al
    Therapeutic efficacy of lenvatinib for patients with unresectable hepatocellular carcinoma based on the middle-term outcome.
    PLoS One. 2020;15:e0231427.
    >> Share

  80. PIEL S, Chamkha I, Dehlin AK, Ehinger JK, et al
    Cell-permeable succinate prodrugs rescue mitochondrial respiration in cellular models of acute acetaminophen overdose.
    PLoS One. 2020;15:e0231173.
    >> Share

  81. YU S, Wang Y, Hou J, Li W, et al
    Tumor-infiltrating immune cells in hepatocellular carcinoma: Tregs is correlated with poor overall survival.
    PLoS One. 2020;15:e0231003.
    >> Share

  82. HAUKELAND JW, Smastuen MC, Palsdatter PP, Ismail M, et al
    Effect of gender on mortality and causes of death in cirrhotic patients with gastroesophageal varices. A retrospective study in Norway.
    PLoS One. 2020;15:e0230263.
    >> Share

  83. ZHANG M, Haughey M, Wang NY, Blease K, et al
    Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs.
    PLoS One. 2020;15:e0229445.
    >> Share

  84. KIRINO S, Tsuchiya K, Kurosaki M, Kaneko S, et al
    Relative dose intensity over the first four weeks of lenvatinib therapy is a factor of favorable response and overall survival in patients with unresectable hepatocellular carcinoma.
    PLoS One. 2020;15:e0231828.
    >> Share

  85. LIU Y, Gao H, He YD
    A compound attributes-based predictive model for drug induced liver injury in humans.
    PLoS One. 2020;15:e0231252.
    >> Share

  86. WU YH, Wu CY, Cheng CY, Tsai SF, et al
    Severe hyperbilirubinemia is associated with higher risk of contrast-related acute kidney injury following contrast-enhanced computed tomography.
    PLoS One. 2020;15:e0231264.
    >> Share

  87. SCHOMAKER S, Potter D, Warner R, Larkindale J, et al
    Serum glutamate dehydrogenase activity enables early detection of liver injury in subjects with underlying muscle impairments.
    PLoS One. 2020;15:e0229753.
    >> Share

  88. NAKANO D, Kawaguchi T, Iwamoto H, Hayakawa M, et al
    Effects of canagliflozin on growth and metabolic reprograming in hepatocellular carcinoma cells: Multi-omics analysis of metabolomics and absolute quantification proteomics (iMPAQT).
    PLoS One. 2020;15:e0232283.
    >> Share

  89. SAITO K, Fukasawa M, Shirasago Y, Suzuki R, et al
    Comparative characterization of flavivirus production in two cell lines: Human hepatoma-derived Huh7.5.1-8 and African green monkey kidney-derived Vero.
    PLoS One. 2020;15:e0232274.
    >> Share

  90. DAVIDSON CQ, Tharmalingam S, Niccoli S, Nemec-Bakk A, et al
    Dose threshold for radiation induced fetal programming in a mouse model at 4 months of age: Hepatic expression of genes and proteins involved in glucose metabolism and glucose uptake in brown adipose tissue.
    PLoS One. 2020;15:e0231650.
    >> Share

  91. BENZ F, Bogen A, Praktiknjo M, Jansen C, et al
    Serum levels of bone sialoprotein correlate with portal pressure in patients with liver cirrhosis.
    PLoS One. 2020;15:e0231701.
    >> Share

  92. SATAPATHY SK, Gonzalez HC, Vanatta J, Dyer A, et al
    A pilot study of ex-vivo MRI-PDFF of donor livers for assessment of steatosis and predicting early graft dysfunction.
    PLoS One. 2020;15:e0232006.
    >> Share

  93. RAIGANI S, Carroll C, Griffith S, Pendexter C, et al
    Improvement of steatotic rat liver function with a defatting cocktail during ex situ normothermic machine perfusion is not directly related to liver fat content.
    PLoS One. 2020;15:e0232886.
    >> Share

  94. CAPUTO F, Dadduzio V, Tovoli F, Bertolini G, et al
    The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib.
    PLoS One. 2020;15:e0232449.
    >> Share

  95. WELBERRY C, Macdonald I, McElveen J, Parsy-Kowalska C, et al
    Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma.
    PLoS One. 2020;15:e0232247.
    >> Share

  96. YU Y, Bai M, Ma F, Zhang W, et al
    Regional citrate anticoagulation versus no-anticoagulation for continuous venovenous hemofiltration in patients with liver failure and increased bleeding risk: A retrospective case-control study.
    PLoS One. 2020;15:e0232516.
    >> Share

  97. PETZOLD G, Lasser J, Ruhl J, Bremer SCB, et al
    Diagnostic accuracy of B-Mode ultrasound and Hepatorenal Index for graduation of hepatic steatosis in patients with chronic liver disease.
    PLoS One. 2020;15:e0231044.
    >> Share

  98. GRIMALDI M, Palisi A, Marino C, Montoro P, et al
    NMR-based metabolomic profile of hypercholesterolemic human sera: Relationship with in vitro gene expression?
    PLoS One. 2020;15:e0231506.
    >> Share

  99. SI H, Genna B, Zhuang X, Wang J, et al
    DaHuangWan targets EGF signaling to inhibit the proliferation of hepatoma cells.
    PLoS One. 2020;15:e0231466.
    >> Share

  100. KANG JK, Heo S, Kim HP, Song SH, et al
    Liquid biopsy-based tumor profiling for metastatic colorectal cancer patients with ultra-deep targeted sequencing.
    PLoS One. 2020;15:e0232754.
    >> Share

  101. WANG Y, Zhou X, Zhao D, Wang X, et al
    Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages and hepatocytes.
    PLoS One. 2020;15:e0232630.
    >> Share

  102. LANZA E, Masetti C, Messana G, Muglia R, et al
    Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma.
    PLoS One. 2020;15:e0232371.
    >> Share

  103. MASUYA T, Suzuki M, Tsujimura J, Kanamori S, et al
    Ablation of Iah1, a candidate gene for diet-induced fatty liver, does not affect liver lipid accumulation in mice.
    PLoS One. 2020;15:e0233087.
    >> Share

  104. CHEN L, Zhang L, Wang W, Qiu W, et al
    Polysaccharides isolated from Cordyceps Sinensis contribute to the progression of NASH by modifying the gut microbiota in mice fed a high-fat diet.
    PLoS One. 2020;15:e0232972.
    >> Share

  105. BELAUNZARAN-ZAMUDIO PF, Caro-Vega Y, Giganti MJ, Castilho JL, et al
    Frequency of non-communicable diseases in people 50 years of age and older receiving HIV care in Latin America.
    PLoS One. 2020;15:e0233965.
    >> Share

  106. NGUYEN TN, Nguyen HQ, Le DH
    Unveiling prognostics biomarkers of tyrosine metabolism reprogramming in liver cancer by cross-platform gene expression analyses.
    PLoS One. 2020;15:e0229276.
    >> Share

  107. NAGATA S, Ozawa F, Nie M, Takeuchi S, et al
    3D culture of functional human iPSC-derived hepatocytes using a core-shell microfiber.
    PLoS One. 2020;15:e0234441.
    >> Share

  108. CHU YW, Chien CH, Sung MI, Chen CW, et al
    dBMHCC: A comprehensive hepatocellular carcinoma (HCC) biomarker database provides a reliable prediction system for novel HCC phosphorylated biomarkers.
    PLoS One. 2020;15:e0234084.
    >> Share

  109. LI C, Ge S, Zhou J, Peng J, et al
    Exploration of the effects of the CYCLOPS gene RBM17 in hepatocellular carcinoma.
    PLoS One. 2020;15:e0234062.
    >> Share

  110. BAEZA-RAJA B, Goodyear A, Liu X, Lam K, et al
    Pharmacological inhibition of P2RX7 ameliorates liver injury by reducing inflammation and fibrosis.
    PLoS One. 2020;15:e0234038.
    >> Share

  111. ALBAKHEET SS, Yoon H, Shin HJ, Koh H, et al
    Bone marrow fat change in pediatric patients with non-alcoholic fatty liver disease.
    PLoS One. 2020;15:e0234096.
    >> Share

  112. MULEY M, Vespasiani-Gentilucci U, De Vincentis A, Santonico M, et al
    Voltammetric analysis for distinguishing portal hypertension-related from malignancy-related ascites: A proof of concept study.
    PLoS One. 2020;15:e0233350.
    >> Share

  113. STOCKHOFF L, Schultalbers M, Tergast TL, Hinrichs JB, et al
    Safety and feasibility of transjugular intrahepatic portosystemic shunt in elderly patients with liver cirrhosis and refractory ascites.
    PLoS One. 2020;15:e0235199.
    >> Share

  114. HAYASHI H, Yamashita YI, Okabe H, Imai K, et al
    Varied application of intercostal trans-diaphragmatic ports for laparoscopic hepatectomy.
    PLoS One. 2020;15:e0234919.
    >> Share

  115. CHANDRASHEKAR DS, Golonka RM, Yeoh BS, Gonzalez DJ, et al
    Fermentable fiber-induced hepatocellular carcinoma in mice recapitulates gene signatures found in human liver cancer.
    PLoS One. 2020;15:e0234726.
    >> Share

  116. QIAO C, Qian H, Wang J, Zhao T, et al
    PD173074 blocks G1/S transition via CUL3-mediated ubiquitin protease in HepG2 and Hep3B cells.
    PLoS One. 2020;15:e0234708.
    >> Share

  117. UESATO Y, Sasahira N, Ozaka M, Sasaki T, et al
    Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasis.
    PLoS One. 2020;15:e0235623.
    >> Share

  118. KOCH C, Bette T, Waidmann O, Filmann N, et al
    AFP ratio predicts HCC recurrence after liver transplantation.
    PLoS One. 2020;15:e0235576.
    >> Share

  119. COHEN AM, Chamberlin S, Deloughery T, Nguyen M, et al
    Detecting rare diseases in electronic health records using machine learning and knowledge engineering: Case study of acute hepatic porphyria.
    PLoS One. 2020;15:e0235574.
    >> Share

  120. NICHOLS PH, Pan Y, May B, Pavlicova M, et al
    Effect of TSH on Non-Alcoholic Fatty Liver Disease (NAFLD) independent of obesity in children of predominantly Hispanic/Latino ancestry by causal mediation analysis.
    PLoS One. 2020;15:e0234985.
    >> Share

  121. SZUCS A, Paku S, Sebestyen E, Nagy P, et al
    Postnatal, ontogenic liver growth accomplished by biliary/oval cell proliferation and differentiation.
    PLoS One. 2020;15:e0233736.
    >> Share

  122. FORTEA JI, Puerto M, Fernandez-Mena C, Asensio I, et al
    Sevoflurane versus ketamine+diazepam anesthesia for assessing systemic and hepatic hemodynamics in rats with non-cirrhotic portal hypertension.
    PLoS One. 2020;15:e0233778.
    >> Share

  123. NUDISCHER R, Renggli K, Hierlemann A, Roth AB, et al
    Characterization of a long-term mouse primary liver 3D tissue model recapitulating innate-immune responses and drug-induced liver toxicity.
    PLoS One. 2020;15:e0235745.
    >> Share

  124. WANG J, Shen P, Liao S, Duan L, et al
    Selenoprotein P inhibits cell proliferation and ROX production in HCC cells.
    PLoS One. 2020;15:e0236491.
    >> Share

  125. KRISS M, Golden-Mason L, Kaplan J, Mirshahi F, et al
    Increased hepatic and circulating chemokine and osteopontin expression occurs early in human NAFLD development.
    PLoS One. 2020;15:e0236353.
    >> Share

  126. GOURRONC FA, Markan KR, Kulhankova K, Zhu Z, et al
    Pdgfralpha-Cre mediated knockout of the aryl hydrocarbon receptor protects mice from high-fat diet induced obesity and hepatic steatosis.
    PLoS One. 2020;15:e0236741.
    >> Share

  127. DIESINGER T, Buko V, Lautwein A, Dvorsky R, et al
    Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis.
    PLoS One. 2020;15:e0235990.
    >> Share

  128. OKUSHIN K, Tsutsumi T, Ikeuchi K, Kado A, et al
    Heterozygous knockout of Bile salt export pump ameliorates liver steatosis in mice fed a high-fat diet.
    PLoS One. 2020;15:e0234750.
    >> Share

  129. PELTONEN R, Gramkow MH, Dehlendorff C, Osterlund PJ, et al
    Elevated serum YKL-40, IL-6, CRP, CEA, and CA19-9 combined as a prognostic biomarker panel after resection of colorectal liver metastases.
    PLoS One. 2020;15:e0236569.
    >> Share

  130. YASUI D, Yamane A, Itoh H, Kobayashi M, et al
    In vivo evaluation of a monodisperse solid-in-oil-in-water miriplatin/ lipiodol emulsion in transcatheter arterial chemoembolization using a rabbit VX2 tumor model.
    PLoS One. 2020;15:e0222553.
    >> Share

  131. STEMMER A, Shadmi R, Bregman-Amitai O, Chettrit D, et al
    Using machine learning algorithms to review computed tomography scans and assess risk for cardiovascular disease: Retrospective analysis from the National Lung Screening Trial (NLST).
    PLoS One. 2020;15:e0236021.
    >> Share

  132. SHEN Q, Hu G, Wu J, Lv L, et al
    A new clinical prognostic nomogram for liver cancer based on immune score.
    PLoS One. 2020;15:e0236622.
    >> Share

  133. YOO JJ, Lim YS, Kim MS, Lee B, et al
    Risk of fatty liver after long-term use of tamoxifen in patients with breast cancer.
    PLoS One. 2020;15:e0236506.
    >> Share

  134. RASHIDI-ALAVIJEH J, Ceylan AS, Wedemeyer H, Kleefisch M, et al
    Standard coagulation tests are superior to thromboelastometry in predicting outcome of patients with liver cirrhosis.
    PLoS One. 2020;15:e0236528.
    >> Share

  135. SERPER M, Vujkovic M, Kaplan DE, Carr RM, et al
    Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program.
    PLoS One. 2020;15:e0237430.
    >> Share

  136. FUKUDA H, Sato D, Moriwaki K, Ishida H, et al
    Differences in healthcare expenditure estimates according to statistical approach: A nationwide claims database study on patients with hepatocellular carcinoma.
    PLoS One. 2020;15:e0237316.
    >> Share

  137. HAL WA, Straza MW, Chen X, Mickevicius N, et al
    Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac.
    PLoS One. 2020;15:e0236570.
    >> Share

  138. CHEN K, Sng WK, Quah JH, Liu J, et al
    Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus.
    PLoS One. 2020;15:e0236977.
    >> Share

  139. FORLANO R, Mullish BH, Mukherjee SK, Nathwani R, et al
    In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19.
    PLoS One. 2020;15:e0240400.
    >> Share

  140. SOGABE M, Okahisa T, Kurihara T, Takehara M, et al
    Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome.
    PLoS One. 2020;15:e0238388.
    >> Share

  141. TAMAI Y, Iwasa M, Eguchi A, Shigefuku R, et al
    Serum copper, zinc and metallothionein serve as potential biomarkers for hepatocellular carcinoma.
    PLoS One. 2020;15:e0237370.
    >> Share

  142. CHANG TT, Ho CH
    Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma.
    PLoS One. 2020;15:e0238251.
    >> Share

  143. LIRA MMP, de Medeiros Filho JEM, Baccin Martins VJ, da Silva G, et al
    Association of worsening of nonalcoholic fatty liver disease with cardiometabolic function and intestinal bacterial overgrowth: A cross-sectional study.
    PLoS One. 2020;15:e0237360.
    >> Share

  144. RONDA OAHO, van de Heijning BJM, de Bruin A, Thomas RE, et al
    Spontaneous liver disease in wild-type C57BL/6JOlaHsd mice fed semisynthetic diet.
    PLoS One. 2020;15:e0232069.
    >> Share

  145. LEE J, Vali Y, Boursier J, Duffin K, et al
    Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0238717.
    >> Share

  146. ROGAL SS, Yakovchenko V, Gonzalez R, Park A, et al
    Characterizing patient-reported outcomes in veterans with cirrhosis.
    PLoS One. 2020;15:e0238712.
    >> Share

  147. HAYASHI M, Abe K, Fujita M, Takahashi A, et al
    Association between serum ficolin-1 level and disease progression in primary biliary cholangitis.
    PLoS One. 2020;15:e0238300.
    >> Share

  148. RAJCIC D, Brandt A, Jin CJ, Sanchez V, et al
    Exchanging dietary fat source with extra virgin olive oil does not prevent progression of diet-induced non-alcoholic fatty liver disease and insulin resistance.
    PLoS One. 2020;15:e0237946.
    >> Share

  149. STRADOMSKA TJ, Syczewska M, Jamroz E, Pleskaczynska A, et al
    Serum very long-chain fatty acids (VLCFA) levels as predictive biomarkers of diseases severity and probability of survival in peroxisomal disorders.
    PLoS One. 2020;15:e0238796.
    >> Share

  150. CORREA F, Hidalgo C, Stoore C, Jimenez M, et al
    Cattle co-infection of Echinococcus granulosus and Fasciola hepatica results in a different systemic cytokine profile than single parasite infection.
    PLoS One. 2020;15:e0238909.
    >> Share

  151. MAUNG K, Ramalingam S, Chaudhry M, Ren Y, et al
    Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality.
    PLoS One. 2020;15:e0238824.
    >> Share

  152. GRIFFETT K, Bedia-Diaz G, Elgendy B, Burris TP, et al
    REV-ERB agonism improves liver pathology in a mouse model of NASH.
    PLoS One. 2020;15:e0236000.
    >> Share

  153. SANTOIEMMA PP, Dakwar O, Angarone MP
    A retrospective analysis of cases of Spontaneous Bacterial Peritonitis in cirrhosis patients.
    PLoS One. 2020;15:e0239470.
    >> Share

  154. LOOSEN SH, Wirtz TH, Roy S, Vucur M, et al
    Circulating levels of microRNA193a-5p predict outcome in early stage hepatocellular carcinoma.
    PLoS One. 2020;15:e0239386.
    >> Share

  155. WANG S, Toy M, Hang Pham TT, So S, et al
    Causes and trends in liver disease and hepatocellular carcinoma among men and women who received liver transplants in the U.S., 2010-2019.
    PLoS One. 2020;15:e0239393.
    >> Share

  156. KANEKO S, Kurosaki M, Nagata K, Taki R, et al
    Liver injury with COVID-19 based on gastrointestinal symptoms and pneumonia severity.
    PLoS One. 2020;15:e0241663.
    >> Share

  157. PENG J, Zhou M, Chen C, Xie X, et al
    Identification of exacerbation risk in patients with liver dysfunction using machine learning algorithms.
    PLoS One. 2020;15:e0239266.
    >> Share

  158. CHOI JW, Lee JM, Lee DH, Yoon JH, et al
    Radiofrequency ablation using internally cooled wet electrodes in bipolar mode for the treatment of recurrent hepatocellular carcinoma after locoregional treatment: A randomized prospective comparative study.
    PLoS One. 2020;15:e0239733.
    >> Share

  159. REY R M, Delgado AF, De Zubiria A, Pinto R, et al
    Prevalence and short-term outcome of hepatorenal syndrome: A 9-year experience in a high-complexity hospital in Colombia.
    PLoS One. 2020;15:e0239834.
    >> Share

  160. RIEXINGER A, Laun FB, Bickelhaupt S, Seuss H, et al
    On the dependence of the cardiac motion artifact on the breathing cycle in liver diffusion-weighted imaging.
    PLoS One. 2020;15:e0239743.
    >> Share

  161. MANN JP, Carter P, Armstrong MJ, Abdelaziz HK, et al
    Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors.
    PLoS One. 2020;15:e0241357.
    >> Share

  162. GOODSON ML, Knotts TA, Campbell EL, Snyder CA, et al
    Specific ablation of the NCoR corepressor delta splice variant reveals alternative RNA splicing as a key regulator of hepatic metabolism.
    PLoS One. 2020;15:e0241238.
    >> Share

  163. KIM MC, Lee JI, Kim JH, Kim HJ, et al
    Serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease.
    PLoS One. 2020;15:e0240195.
    >> Share

  164. SORINO P, Caruso MG, Misciagna G, Bonfiglio C, et al
    Selecting the best machine learning algorithm to support the diagnosis of Non-Alcoholic Fatty Liver Disease: A meta learner study.
    PLoS One. 2020;15:e0240867.
    >> Share

  165. HASSAN S, Peluso J, Chalhoub S, Idoux Gillet Y, et al
    Quercetin potentializes the respective cytotoxic activity of gemcitabine or doxorubicin on 3D culture of AsPC-1 or HepG2 cells, through the inhibition of HIF-1alpha and MDR1.
    PLoS One. 2020;15:e0240676.
    >> Share

  166. LIN YJ, Lin CN, Sedghi T, Hsu SH, et al
    Treatment patterns and survival in hepatocellular carcinoma in the United States and Taiwan.
    PLoS One. 2020;15:e0240542.
    >> Share

  167. ZHANG L, Yuan Q, Xu Y, Wang W, et al
    Comparative clinical outcomes of robot-assisted liver resection versus laparoscopic liver resection: A meta-analysis.
    PLoS One. 2020;15:e0240593.
    >> Share

  168. CHURCH RJ, Schomaker SJ, Eaddy JS, Boucher GG, et al
    Glutamate dehydrogenase as a biomarker for mitotoxicity; insights from furosemide hepatotoxicity in the mouse.
    PLoS One. 2020;15:e0240562.
    >> Share

  169. YAN B, Luo J, Kaltenmeier C, Du Q, et al
    Interferon Regulatory Factor-1 (IRF1) activates autophagy to promote liver ischemia/reperfusion injury by inhibiting beta-catenin in mice.
    PLoS One. 2020;15:e0239119.
    >> Share

  170. GRANATA V, Fusco R, Avallone A, Cassata A, et al
    Abbreviated MRI protocol for colorectal liver metastases: How the radiologist could work in pre surgical setting.
    PLoS One. 2020;15:e0241431.
    >> Share

  171. BAUMLER W, Schicho A, Schaible J, Verloh N, et al
    Changes in gadoxetic-acid-enhanced MR imaging during the first year after irreversible electroporation of malignant hepatic tumors.
    PLoS One. 2020;15:e0242093.
    >> Share

  172. ZHAO Y, Zhu C, Chang Q, Peng P, et al
    MiR-424-5p regulates cell cycle and inhibits proliferation of hepatocellular carcinoma cells by targeting E2F7.
    PLoS One. 2020;15:e0242179.
    >> Share

  173. GUO B, Tan X, Cen H
    EZH2 is a negative prognostic biomarker associated with immunosuppression in hepatocellular carcinoma.
    PLoS One. 2020;15:e0242191.
    >> Share

  174. FENG L, Dong K, Zhang X, Ma B, et al
    Clinical significance of IgG antimitochondrial M2 antibody levels in primary biliary cholangitis: A single center study from China.
    PLoS One. 2020;15:e0242164.
    >> Share

  175. CHEN HY, Lu SN, Hung CH, Wang JH, et al
    Predicting outcomes for recurrent hepatocellular carcinoma within Milan criteria after complete radiofrequency ablation.
    PLoS One. 2020;15:e0242113.
    >> Share

  176. GALIERO R, Pafundi PC, Simeon V, Rinaldi L, et al
    Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study.
    PLoS One. 2020;15:e0243700.
    >> Share

  177. VISARIA A, Pai S, Fayngersh A, Kothari N, et al
    Association between alanine aminotransferase within the normal range and all-cause and cause-specific mortality: A nationwide cohort study.
    PLoS One. 2020;15:e0242431.
    >> Share

  178. SAKAMAKI A, Yokoyama K, Koyama K, Morita S, et al
    Obesity and accumulation of subcutaneous adipose tissue are poor prognostic factors in patients with alcoholic liver cirrhosis.
    PLoS One. 2020;15:e0242582.
    >> Share

  179. PARK JH, Chung YE, Seo N, Choi JY, et al
    Gadoxetic acid-enhanced MRI of hepatocellular carcinoma: Diagnostic performance of category-adjusted LR-5 using modified criteria.
    PLoS One. 2020;15:e0242344.
    >> Share

  180. CHOI J, Kim SH, Han S, Lee D, et al
    A simple and clinically applicable model to predict liver-related morbidity after hepatic resection for hepatocellular carcinoma.
    PLoS One. 2020;15:e0241808.
    >> Share

  181. CHIU TJ, Chen YJ, Kuo FY, Chen YY, et al
    Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular-cholangiocarcinoma.
    PLoS One. 2020;15:e0240791.
    >> Share

  182. MOLE DJ, Fallowfield JA, Sherif AE, Kendall T, et al
    Quantitative magnetic resonance imaging predicts individual future liver performance after liver resection for cancer.
    PLoS One. 2020;15:e0238568.
    >> Share

  183. LEUNG CCT, Wong CKC
    Effects of stanniocalcin-1 overexpressing hepatocellular carcinoma cells on macrophage migration.
    PLoS One. 2020;15:e0241932.
    >> Share

  184. PALLADINI G, Ferrigno A, Di Pasqua LG, Berardo C, et al
    Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease.
    PLoS One. 2020;15:e0243179.
    >> Share

  185. LUONG XG, Stevens SK, Jekle A, Lin TI, et al
    Regulation of gene transcription by thyroid hormone receptor beta agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH).
    PLoS One. 2020;15:e0240338.
    >> Share

  186. HIROSE S, Matsumoto K, Tatemichi M, Tsuruya K, et al
    Nineteen-year prognosis in Japanese patients with biopsy-proven nonalcoholic fatty liver disease: Lean versus overweight patients.
    PLoS One. 2020;15:e0241770.
    >> Share

  187. XIAO C, Fu X, Wang Y, Liu H, et al
    Transferrin receptor regulates malignancies and the stemness of hepatocellular carcinoma-derived cancer stem-like cells by affecting iron accumulation.
    PLoS One. 2020;15:e0243812.
    >> Share

  188. ADHYAPOK P, Fu X, Sluka JP, Clendenon SG, et al
    A computational model of liver tissue damage and repair.
    PLoS One. 2020;15:e0243451.
    >> Share

  189. BRAUNWARTH E, Rumpf B, Primavesi F, Pereyra D, et al
    Sex differences in disease presentation, surgical and oncological outcome of liver resection for primary and metastatic liver tumors-A retrospective multicenter study.
    PLoS One. 2020;15:e0243539.
    >> Share

  190. LEE S, Kim JH, Moon H, Lee HJ, et al
    Combined treatment of sorafenib and doxorubicin-loaded microbubble-albumin nanoparticle complex for hepatocellular carcinoma: A feasibility study.
    PLoS One. 2020;15:e0243815.
    >> Share

  191. BAYOUMI A, Jalil I, Metwally M, Adams LA, et al
    Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease.
    PLoS One. 2020;15:e0243590.
    >> Share

  192. BAE CR, Zhang H, Kwon YG
    The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice.
    PLoS One. 2020;15:e0243497.
    >> Share

  193. SOHN W, Ham CB, Kim NH, Kim HJ, et al
    Effect of acute kidney injury on the patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
    PLoS One. 2020;15:e0243780.
    >> Share

  194. YEN FS, Lai JN, Wei JC, Chiu LT, et al
    Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis.
    PLoS One. 2020;15:e0243783.
    >> Share

  195. YUAN Y, Naito H, Kitamori K, Hashimoto S, et al
    The antihypertensive agent hydralazine reduced extracellular matrix synthesis and liver fibrosis in nonalcoholic steatohepatitis exacerbated by hypertension.
    PLoS One. 2020;15:e0243846.
    >> Share

  196. WANG G, Wang Q, Bai J, Li G, et al
    RYGB increases postprandial gastric nesfatin-1 and rapid relieves NAFLD via gastric nerve detachment.
    PLoS One. 2020;15:e0243640.
    >> Share

  197. LIU L, Liu C, Zhao M, Zhang Q, et al
    The pharmacodynamic and differential gene expression analysis of PPAR alpha/delta agonist GFT505 in CDAHFD-induced NASH model.
    PLoS One. 2020;15:e0243911.
    >> Share

  198. MANJARIN R, Maj MA, La Frano MR, Glanz H, et al
    %polynova_2way: A SAS macro for implementation of mixed models for metabolomics data.
    PLoS One. 2020;15:e0244013.
    >> Share

  199. HSIEH MH, Kao TY, Hsieh TH, Kao CC, et al
    Prognostic roles of diabetes mellitus and hypertension in advanced hepatocellular carcinoma treated with sorafenib.
    PLoS One. 2020;15:e0244293.
    >> Share

  200. WEISSINGER M, Vogel J, Kupferschlager J, Dittmann H, et al
    Correlation of C-arm CT acquired parenchymal blood volume (PBV) with 99mTc-macroaggregated albumin (MAA) SPECT/CT for radioembolization work-up.
    PLoS One. 2020;15:e0244235.
    >> Share

  201. RYU H, Kim JH, Lee S, Han JK, et al
    Therapeutic response monitoring after targeted therapy in an orthotopic rat model of hepatocellular carcinoma using contrast-enhanced ultrasound: Focusing on inter-scanner, and inter-operator reproducibility.
    PLoS One. 2020;15:e0244304.
    >> Share

  202. SEMMLER G, Bachmayer S, Wernly S, Wernly B, et al
    Nut consumption and the prevalence and severity of non-alcoholic fatty liver disease.
    PLoS One. 2020;15:e0244514.
    >> Share

  203. BORTOLAMI M, Comparato A, Benna C, Errico A, et al
    Gene and protein expression of mTOR and LC3 in hepatocellular carcinoma, colorectal liver metastasis and "normal" liver tissues.
    PLoS One. 2020;15:e0244356.
    >> Share

  204. HAYASHI T, Shibata M, Oe S, Miyagawa K, et al
    C-reactive protein can predict dose intensity, time to treatment failure and overall survival in HCC treated with lenvatinib.
    PLoS One. 2020;15:e0244370.
    >> Share

  205. THULUVATH PJ, Amjad W, Zhang T
    Liver transplant waitlist removal, transplantation rates and post-transplant survival in Hispanics.
    PLoS One. 2020;15:e0244744.
    >> Share

  206. PILLING D, Karhadkar TR, Gomer RH
    A CD209 ligand and a sialidase inhibitor differentially modulate adipose tissue and liver macrophage populations and steatosis in mice on the Methionine and Choline-Deficient (MCD) diet.
    PLoS One. 2020;15:e0244762.
    >> Share

    January 2019
  207. CHAO X, Wang G, Tang Y, Dong C, et al
    The effects and mechanism of peiminine-induced apoptosis in human hepatocellular carcinoma HepG2 cells.
    PLoS One. 2019;14:e0201864.
    >> Share

  208. SONG JU, Jang Y, Lim SY, Ryu S, et al
    Decreased lung function is associated with risk of developing non-alcoholic fatty liver disease: A longitudinal cohort study.
    PLoS One. 2019;14:e0208736.
    >> Share

  209. SEPULVEDA-VILLEGAS M, Roman S, Rivera-Iniguez I, Ojeda-Granados C, et al
    High prevalence of nonalcoholic steatohepatitis and abnormal liver stiffness in a young and obese Mexican population.
    PLoS One. 2019;14:e0208926.
    >> Share

  210. NORONA LM, Nguyen DG, Gerber DA, Presnell SC, et al
    Bioprinted liver provides early insight into the role of Kupffer cells in TGF-beta1 and methotrexate-induced fibrogenesis.
    PLoS One. 2019;14:e0208958.
    >> Share

  211. OHASHI T, Nakade Y, Ibusuki M, Kitano R, et al
    Conophylline inhibits high fat diet-induced non-alcoholic fatty liver disease in mice.
    PLoS One. 2019;14:e0210068.
    >> Share

  212. KWON J, Kim S, Yoo H, Lee E, et al
    Nimesulide-induced hepatotoxicity: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0209264.
    >> Share

  213. CHEN QF, Huang T, Shen L, Li W, et al
    Predictive value of a nomogram for hepatocellular carcinoma with brain metastasis at initial diagnosis: A population-based study.
    PLoS One. 2019;14:e0209293.
    >> Share

  214. NISHIMURA T, Takami T, Sasaki R, Aibe Y, et al
    Liver regeneration therapy through the hepatic artery-infusion of cultured bone marrow cells in a canine liver fibrosis model.
    PLoS One. 2019;14:e0210588.
    >> Share

  215. MELIS M, Tang XH, Trasino SE, Patel VM, et al
    Effects of AM80 compared to AC261066 in a high fat diet mouse model of liver disease.
    PLoS One. 2019;14:e0211071.
    >> Share

  216. SINN DH, Choi GS, Park HC, Kim JM, et al
    Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients.
    PLoS One. 2019;14:e0210730.
    >> Share

  217. HASHEM MM, Salama MM, Mohammed FF, Tohamy AF, et al
    Metabolic profile and hepatoprotective effect of Aeschynomene elaphroxylon (Guill. & Perr.).
    PLoS One. 2019;14:e0210576.
    >> Share

  218. PAQUETTE K, Coltin H, Boivin A, Amre D, et al
    Cancer risk in children and young adults born preterm: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0210366.
    >> Share

  219. YU MH, Kim YJ, Park HS, Jung SI, et al
    Shrinkage of hepatocellular carcinoma after radiofrequency ablation following transcatheter arterial chemoembolization: Analysis of contributing factors.
    PLoS One. 2019;14:e0210667.
    >> Share

  220. WANG S, Shen HW, Chai H, Liang Y, et al
    Complex harmonic regularization with differential evolution in a memetic framework for biomarker selection.
    PLoS One. 2019;14:e0210786.
    >> Share

  221. CHOUNG S, Kim JM, Joung KH, Lee ES, et al
    Epidermal growth factor receptor inhibition attenuates non-alcoholic fatty liver disease in diet-induced obese mice.
    PLoS One. 2019;14:e0210828.
    >> Share

  222. APPLEBY RN, Moghul I, Khan S, Yee M, et al
    Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea: A prospective observational study.
    PLoS One. 2019;14:e0211348.
    >> Share

  223. KIM SH, Kim JK, Park EY, Joo J, et al
    Liver metastasis and Heng risk are prognostic factors in patients with non-nephrectomized synchronous metastatic renal cell carcinoma treated with systemic therapy.
    PLoS One. 2019;14:e0211105.
    >> Share

  224. TAKADA H, Kurosaki M, Nakanishi H, Takahashi Y, et al
    Real-life experience of lusutrombopag for cirrhotic patients with low platelet counts being prepared for invasive procedures.
    PLoS One. 2019;14:e0211122.
    >> Share

  225. KLOSE J, Trefz S, Wagner T, Steffen L, et al
    Salinomycin: Anti-tumor activity in a pre-clinical colorectal cancer model.
    PLoS One. 2019;14:e0211916.
    >> Share

  226. WANG Y, Cobanoglu MC, Li J, Hidvegi T, et al
    An analog of glibenclamide selectively enhances autophagic degradation of misfolded alpha1-antitrypsin Z.
    PLoS One. 2019;14:e0209748.
    >> Share

  227. MAKONDI PT, Wei PL, Huang CY, Chang YJ, et al
    Development of novel predictive miRNA/target gene pathways for colorectal cancer distance metastasis to the liver using a bioinformatic approach.
    PLoS One. 2019;14:e0211968.
    >> Share

  228. TOLEDANO MN, Vera P, Tilly H, Jardin F, et al
    Comparison of therapeutic evaluation criteria in FDG-PET/CT in patients with diffuse large-cell B-cell lymphoma: Prognostic impact of tumor/liver ratio.
    PLoS One. 2019;14:e0211649.
    >> Share

  229. SCHWARZKOPF KM, Queck A, Thomas D, Angioni C, et al
    Omega-3 and -6 fatty acid plasma levels are not associated with liver cirrhosis-associated systemic inflammation.
    PLoS One. 2019;14:e0211537.
    >> Share

  230. LEE YJ, Shu MS, Kim JY, Kim YH, et al
    Cilostazol protects hepatocytes against alcohol-induced apoptosis via activation of AMPK pathway.
    PLoS One. 2019;14:e0211415.
    >> Share

  231. ISHIKAWA T, Yokoyama H, Matsuura T, Fujiwara Y, et al
    Fc gamma RIIb expression levels in human liver sinusoidal endothelial cells during progression of non-alcoholic fatty liver disease.
    PLoS One. 2019;14:e0211543.
    >> Share

  232. MUKTHINUTHALAPATI VVPK, Akinyeye S, Fricker ZP, Syed M, et al
    Early predictors of outcomes of hospitalization for cirrhosis and assessment of the impact of race and ethnicity at safety-net hospitals.
    PLoS One. 2019;14:e0211811.
    >> Share

  233. WALKER S, Wankell M, Ho V, White R, et al
    Targeting mTOR and Src restricts hepatocellular carcinoma growth in a novel murine liver cancer model.
    PLoS One. 2019;14:e0212860.
    >> Share

  234. REUSCHEL E, Jilg W, Seelbach-Goebel B, Deml L, et al
    Comparative purification and characterization of hepatitis B virus-like particles produced by recombinant vaccinia viruses in human hepatoma cells and human primary hepatocytes.
    PLoS One. 2019;14:e0212800.
    >> Share

  235. XIONG X, Yu J, Fan R, Zhang C, et al
    NAMPT overexpression alleviates alcohol-induced hepatic steatosis in mice.
    PLoS One. 2019;14:e0212523.
    >> Share

  236. IMAI Y, Yoshida O, Watanabe T, Yukimoto A, et al
    Stimulated hepatic stellate cell promotes progression of hepatocellular carcinoma due to protein kinase R activation.
    PLoS One. 2019;14:e0212589.
    >> Share

  237. TURCIOS L, Chacon E, Garcia C, Eman P, et al
    Autophagic flux modulation by Wnt/beta-catenin pathway inhibition in hepatocellular carcinoma.
    PLoS One. 2019;14:e0212538.
    >> Share

  238. YAMADA S, Shimada M, Morine Y, Imura S, et al
    A new formula to calculate the resection limit in hepatectomy based on Gd-EOB-DTPA-enhanced magnetic resonance imaging.
    PLoS One. 2019;14:e0210579.
    >> Share

  239. WEI PL, Huang CY, Chang YJ
    Propyl gallate inhibits hepatocellular carcinoma cell growth through the induction of ROS and the activation of autophagy.
    PLoS One. 2019;14:e0210513.
    >> Share

  240. CHIU SY, Chung HJ, Chen YT, Huang MS, et al
    A nonsense mutant of the hepatitis B virus large S protein antagonizes multiple tumor suppressor pathways through c-Jun activation domain-binding protein1.
    PLoS One. 2019;14:e0208665.
    >> Share

  241. MOSHER V, Swain M, Pang J, Kaplan G, et al
    Primary biliary cholangitis patients exhibit MRI changes in structure and function of interoceptive brain regions.
    PLoS One. 2019;14:e0211906.
    >> Share

  242. KIM J, Sinn DH, Choi MS, Kang W, et al
    Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?
    PLoS One. 2019;14:e0213547.
    >> Share

  243. YANG B, Pan CS, Li Q, Yang Z, et al
    Inhibitory effects of Chanling Gao on the proliferation and liver metastasis of transplanted colorectal cancer in nude mice.
    PLoS One. 2019;14:e0201504.
    >> Share

  244. BAI X, Liu Z, Shao X, Wang D, et al
    The heterogeneity of plasma miRNA profiles in hepatocellular carcinoma patients and the exploration of diagnostic circulating miRNAs for hepatocellular carcinoma.
    PLoS One. 2019;14:e0211581.
    >> Share

  245. GEBRELIBANOS HIBEN M, de Haan L, Spenkelink B, Wesseling S, et al
    Effects of Maerua subcordata (Gilg) DeWolf on electrophile-responsive element (EpRE)-mediated gene expression in vitro.
    PLoS One. 2019;14:e0215155.
    >> Share

  246. JAMES G, Reisberg S, Lepik K, Galwey N, et al
    An exploratory phenome wide association study linking asthma and liver disease genetic variants to electronic health records from the Estonian Biobank.
    PLoS One. 2019;14:e0215026.
    >> Share

  247. SCHMILOVITZ-WEISS H, Gingold-Belfer R, Grossman A, Issa N, et al
    Lowering the upper limit of serum alanine aminotransferase levels may reveal significant liver disease in the elderly.
    PLoS One. 2019;14:e0212737.
    >> Share

  248. STAFMAN LL, Williams AP, Marayati R, Aye JM, et al
    PP2A activation alone and in combination with cisplatin decreases cell growth and tumor formation in human HuH6 hepatoblastoma cells.
    PLoS One. 2019;14:e0214469.
    >> Share

  249. TOLEDANO MB, Mukherjee SK, Howell J, Westaby D, et al
    The emerging burden of liver disease in cystic fibrosis patients: A UK nationwide study.
    PLoS One. 2019;14:e0212779.
    >> Share

  250. SINGH A, Banerjee T, Kumar R, Shukla SK, et al
    Prevalence of cases of amebic liver abscess in a tertiary care centre in India: A study on risk factors, associated microflora and strain variation of Entamoeba histolytica.
    PLoS One. 2019;14:e0214880.
    >> Share

  251. WILLSON NL, Van TTH, Bhattarai SP, Courtice JM, et al
    Feed supplementation with biochar may reduce poultry pathogens, including Campylobacter hepaticus, the causative agent of Spotty Liver Disease.
    PLoS One. 2019;14:e0214471.
    >> Share

  252. GARCIA-JARAMILLO M, Spooner MH, Lohr CV, Wong CP, et al
    Lipidomic and transcriptomic analysis of western diet-induced nonalcoholic steatohepatitis (NASH) in female Ldlr -/- mice.
    PLoS One. 2019;14:e0214387.
    >> Share

  253. DING S, Yuan C, Si B, Wang M, et al
    Combined effects of ambient particulate matter exposure and a high-fat diet on oxidative stress and steatohepatitis in mice.
    PLoS One. 2019;14:e0214680.
    >> Share

  254. CANBAY A, Kalsch J, Neumann U, Rau M, et al
    Non-invasive assessment of NAFLD as systemic disease-A machine learning perspective.
    PLoS One. 2019;14:e0214436.
    >> Share

  255. YUN Y, Kim HN, Lee EJ, Ryu S, et al
    Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects.
    PLoS One. 2019;14:e0213692.
    >> Share

  256. LIU B, Anno K, Kobayashi T, Piao J, et al
    Influence of donor liver telomere and G-tail on clinical outcome after living donor liver transplantation.
    PLoS One. 2019;14:e0213462.
    >> Share

  257. FAHLENKAMP UL, Engel G, Adams LC, Boker SM, et al
    Improved visualisation of hepatic metastases in gadoxetate disodium-enhanced MRI: Potential of contrast-optimised (phase-sensitive) inversion recovery imaging.
    PLoS One. 2019;14:e0213408.
    >> Share

  258. FARD N, Schlemmer HP, Raue F, Jobke B, et al
    CT- and ultrasound-characteristics of hepatic lesions in patients with multiple endocrine neoplasia syndrome. A retrospective image review of 25 cases.
    PLoS One. 2019;14:e0212865.
    >> Share

  259. LUO X, Zhao M, Wang X, Jiang M, et al
    Long-term patency and clinical outcome of the transjugular intrahepatic portosystemic shunt using the expanded polytetrafluoroethylene stent-graft.
    PLoS One. 2019;14:e0212658.
    >> Share

  260. NUNEZ KG, Frank A, Gonzalez-Rosario J, Galliano G, et al
    Interleukin-33 / Cyclin D1 imbalance in severe liver steatosis predicts susceptibility to ischemia reperfusion injury.
    PLoS One. 2019;14:e0216242.
    >> Share

  261. HUNG TH, Tseng CW, Tsai CC, Lee HF, et al
    Effect of proton pump inhibitors on mortality of cirrhotic patients with pneumonia.
    PLoS One. 2019;14:e0216041.
    >> Share

  262. MIGLIACCIO V, Scudiero R, Sica R, Lionetti L, et al
    Oxidative stress and mitochondrial uncoupling protein 2 expression in hepatic steatosis induced by exposure to xenobiotic DDE and high fat diet in male Wistar rats.
    PLoS One. 2019;14:e0215955.
    >> Share

  263. HUNG TH, Tsai CC, Lee HF
    Statin use in cirrhotic patients with infectious diseases: A population-based study.
    PLoS One. 2019;14:e0215839.
    >> Share

  264. BACHTIAR V, Kelly MD, Wilman HR, Jacobs J, et al
    Repeatability and reproducibility of multiparametric magnetic resonance imaging of the liver.
    PLoS One. 2019;14:e0214921.
    >> Share

  265. AMIN S, Rattner J, Keramati MR, Farshidfar F, et al
    A strategy for early detection of response to chemotherapy drugs based on treatment-related changes in the metabolome.
    PLoS One. 2019;14:e0213942.
    >> Share

  266. BELMONTE FR, Dedousis N, Sipula I, Desai NA, et al
    Petite Integration Factor 1 (PIF1) helicase deficiency increases weight gain in Western diet-fed female mice without increased inflammatory markers or decreased glucose clearance.
    PLoS One. 2019;14:e0203101.
    >> Share

  267. TOKSVANG LN, Schmidt MS, Arup S, Larsen RH, et al
    Hepatotoxicity during 6-thioguanine treatment in inflammatory bowel disease and childhood acute lymphoblastic leukaemia: A systematic review.
    PLoS One. 2019;14:e0212157.
    >> Share

  268. KESSLER SM, Leber B, Hoppstadter J, Golob-Schwarzl N, et al
    Diethylnitrosamine (DENA) recapitulates formation of hepatic angiosarcoma in pigs.
    PLoS One. 2019;14:e0214756.
    >> Share

  269. VERLOH N, Probst U, Utpatel K, Zeman F, et al
    Influence of hepatic fibrosis and inflammation: Correlation between histopathological changes and Gd-EOB-DTPA-enhanced MR imaging.
    PLoS One. 2019;14:e0215752.
    >> Share

  270. ANWAR SL, Hasemeier B, Schipper E, Vogel A, et al
    LINE-1 hypomethylation in human hepatocellular carcinomas correlates with shorter overall survival and CIMP phenotype.
    PLoS One. 2019;14:e0216374.
    >> Share

  271. LEE YG, Chang Y, Kang J, Koo DH, et al
    Risk factors for incident anemia of chronic diseases: A cohort study.
    PLoS One. 2019;14:e0216062.
    >> Share

  272. SINGH N, Kallollimath P, Shah MH, Kapoor S, et al
    Genetic analysis of ATP7B in 102 south Indian families with Wilson disease.
    PLoS One. 2019;14:e0215779.
    >> Share

  273. MEISCHL T, Rasoul-Rockenschaub S, Gyori G, Sieghart W, et al
    C-reactive protein is an independent predictor for hepatocellular carcinoma recurrence after liver transplantation.
    PLoS One. 2019;14:e0216677.
    >> Share

  274. CHANG PY, Chung CH, Chang WC, Lin CS, et al
    The effect of propranolol on the prognosis of hepatocellular carcinoma: A nationwide population-based study.
    PLoS One. 2019;14:e0216828.
    >> Share

  275. WETZ C, Genseke P, Apostolova I, Furth C, et al
    The association of intra-therapeutic heterogeneity of somatostatin receptor expression with morphological treatment response in patients undergoing PRRT with [177Lu]-DOTATATE.
    PLoS One. 2019;14:e0216781.
    >> Share

  276. ZHAO Z, Wu W, Duan X, Zeng G, et al
    The value of cytoreductive nephrectomy on the survival of metastatic renal carcinoma patients based on the number of site-specific metastases.
    PLoS One. 2019;14:e0215861.
    >> Share

  277. JEON MY, Kim HS, Lim TS, Han DH, et al
    Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection.
    PLoS One. 2019;14:e0214613.
    >> Share

  278. WANG Z, Gu X, Thrift AP
    Factors associated with favorable survival outcomes for Asians with hepatocellular carcinoma: A sequential matching cohort study.
    PLoS One. 2019;14:e0214721.
    >> Share

  279. GUPTA P, Sata TN, Yadav AK, Mishra A, et al
    TGF-beta induces liver fibrosis via miRNA-181a-mediated down regulation of augmenter of liver regeneration in hepatic stellate cells.
    PLoS One. 2019;14:e0214534.
    >> Share

  280. LAWRENCE YA, Guard BC, Steiner JM, Suchodolski JS, et al
    Untargeted metabolomic profiling of urine from healthy dogs and dogs with chronic hepatic disease.
    PLoS One. 2019;14:e0217797.
    >> Share

  281. GASSER E, Braunwarth E, Riedmann M, Cardini B, et al
    Primary tumour location affects survival after resection of colorectal liver metastases: A two-institutional cohort study with international validation, systematic meta-analysis and a clinical risk score.
    PLoS One. 2019;14:e0217411.
    >> Share

  282. HAMAOKA M, Kobayashi T, Tanaka Y, Mashima H, et al
    Clinical significance of glypican-3-positive circulating tumor cells of hepatocellular carcinoma patients: A prospective study.
    PLoS One. 2019;14:e0217586.
    >> Share

  283. SOMMA F, Stoia V, Serra N, D'Angelo R, et al
    Yttrium-90 trans-arterial radioembolization in advanced-stage HCC: The impact of portal vein thrombosis on survival.
    PLoS One. 2019;14:e0216935.
    >> Share

  284. LI F, Dong YZ, Zhang D, Zhang XM, et al
    Molecular mechanisms involved in drug-induced liver injury caused by urate-lowering Chinese herbs: A network pharmacology study and biology experiments.
    PLoS One. 2019;14:e0216948.
    >> Share

  285. GANI SA, Muhammad SA, Kura AU, Barahuie F, et al
    Effect of protocatechuic acid-layered double hydroxide nanoparticles on diethylnitrosamine/phenobarbital-induced hepatocellular carcinoma in mice.
    PLoS One. 2019;14:e0217009.
    >> Share

  286. SOMDA S, Lebrun A, Tranchart H, Lamouri K, et al
    Adaptation of controlled attenuation parameter (CAP) measurement depth in morbidly obese patients addressed for bariatric surgery.
    PLoS One. 2019;14:e0217093.
    >> Share

  287. CARBONELL G, Berna-Serna JD, Oltra L, Martinez CM, et al
    Evaluation of rat liver with ARFI elastography: In vivo and ex vivo study.
    PLoS One. 2019;14:e0217297.
    >> Share

  288. EL AWDAN SA, Abdel Rahman RF, Ibrahim HM, Hegazy RR, et al
    Regression of fibrosis by cilostazol in a rat model of thioacetamide-induced liver fibrosis: Up regulation of hepatic cAMP, and modulation of inflammatory, oxidative stress and apoptotic biomarkers.
    PLoS One. 2019;14:e0216301.
    >> Share

  289. WITTAUER EM, Oldhafer F, Augstein E, Beetz O, et al
    Porcine model for the study of liver regeneration enhanced by non-invasive 13C-methacetin breath test (LiMAx test) and permanent portal venous access.
    PLoS One. 2019;14:e0217488.
    >> Share

  290. CUMSILLE P, Godoy M, Gerdtzen ZP, Conca C, et al
    Parameter estimation and mathematical modeling for the quantitative description of therapy failure due to drug resistance in gastrointestinal stromal tumor metastasis to the liver.
    PLoS One. 2019;14:e0217332.
    >> Share

  291. CHLEBUS G, Meine H, Thoduka S, Abolmaali N, et al
    Reducing inter-observer variability and interaction time of MR liver volumetry by combining automatic CNN-based liver segmentation and manual corrections.
    PLoS One. 2019;14:e0217228.
    >> Share

  292. HERATH RP, Siriwardana SR, Ekanayake CD, Abeysekara V, et al
    Non-alcoholic fatty liver disease and pregnancy complications among Sri Lankan women: A cross sectional analytical study.
    PLoS One. 2019;14:e0215326.
    >> Share

  293. HONG M, Hwang JT, Shin EJ, Hur HJ, et al
    Genome-wide analysis of DNA methylation identifies novel differentially methylated regions associated with lipid accumulation improved by ethanol extracts of Allium tubersosum and Capsella bursa-pastoris in a cell model.
    PLoS One. 2019;14:e0217877.
    >> Share

  294. JANSEN MJA, Kuijf HJ, Veldhuis WB, Wessels FJ, et al
    Automatic classification of focal liver lesions based on MRI and risk factors.
    PLoS One. 2019;14:e0217053.
    >> Share

  295. PARK J, Lee J, Kwon A, Choi HJ, et al
    The 2016 ASE/EACVI recommendations may be able to more accurately identify patients at risk for diastolic dysfunction in living donor liver transplantation.
    PLoS One. 2019;14:e0215603.
    >> Share

  296. FELL GL, Anez-Bustillos L, Dao DT, Baker MA, et al
    Alpha-tocopherol in intravenous lipid emulsions imparts hepatic protection in a murine model of hepatosteatosis induced by the enteral administration of a parenteral nutrition solution.
    PLoS One. 2019;14:e0217155.
    >> Share

  297. YEE C, Main NM, Terry A, Stevanovski I, et al
    CD147 mediates intrahepatic leukocyte aggregation and determines the extent of liver injury.
    PLoS One. 2019;14:e0215557.
    >> Share

  298. KAR S, Paglialunga S, Jaycox SH, Islam R, et al
    Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis.
    PLoS One. 2019;14:e0217263.
    >> Share

  299. PEDROZA M, To S, Smith J, Agarwal SK, et al
    Cadherin-11 contributes to liver fibrosis induced by carbon tetrachloride.
    PLoS One. 2019;14:e0218971.
    >> Share

  300. PENG CH, Lee HC, Jiang CB, Hsu CK, et al
    Serum vitamin D level is inversely associated with liver fibrosis in post Kasai's portoenterostomy biliary atresia patients living with native liver.
    PLoS One. 2019;14:e0218896.
    >> Share

  301. RIBERA J, Rodriguez-Vita J, Cordoba B, Portoles I, et al
    Functionalized cerium oxide nanoparticles mitigate the oxidative stress and pro-inflammatory activity associated to the portal vein endothelium of cirrhotic rats.
    PLoS One. 2019;14:e0218716.
    >> Share

  302. SALIC K, Kleemann R, Wilkins-Port C, McNulty J, et al
    Apical sodium-dependent bile acid transporter inhibition with volixibat improves metabolic aspects and components of non-alcoholic steatohepatitis in Ldlr-/-.Leiden mice.
    PLoS One. 2019;14:e0218459.
    >> Share

  303. LEE SK, Song MJ, Kim SH, Park M, et al
    Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study.
    PLoS One. 2019;14:e0216173.
    >> Share

  304. PANG K, Zhu Z, Zhu S, Han L, et al
    A high dose of conjugated linoleic acid increases fatty liver and insulin resistance in lactating mice.
    PLoS One. 2019;14:e0214903.
    >> Share

  305. KONG J, Wang T, Shen S, Zhang Z, et al
    A nomogram predicting the prognosis of young adult patients diagnosed with hepatocellular carcinoma: A population-based analysis.
    PLoS One. 2019;14:e0219654.
    >> Share

  306. DOLD L, Nielsen MJ, Praktiknjo M, Schwarze-Zander C, et al
    Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART.
    PLoS One. 2019;14:e0219526.
    >> Share

  307. HAGE C, Hoves S, Ashoff M, Schandl V, et al
    Characterizing responsive and refractory orthotopic mouse models of hepatocellular carcinoma in cancer immunotherapy.
    PLoS One. 2019;14:e0219517.
    >> Share

  308. MAIPANG K, Potranun P, Chainuvati S, Nimanong S, et al
    Validation of the prognostic models in acute-on-chronic liver failure precipitated by hepatic and extrahepatic insults.
    PLoS One. 2019;14:e0219516.
    >> Share

  309. DONNER DB, Nakakura EK, Venook AP, Lenz HJ, et al
    High thymidylate synthase gene expression predicts poor outcome after resection of hepatocellular carcinoma.
    PLoS One. 2019;14:e0219469.
    >> Share

  310. PENG W, Li JW, Zhang XY, Li C, et al
    A novel model for predicting posthepatectomy liver failure in patients with hepatocellular carcinoma.
    PLoS One. 2019;14:e0219219.
    >> Share

  311. WANG H, Lu J, Dolezal J, Kulkarni S, et al
    Inhibition of hepatocellular carcinoma by metabolic normalization.
    PLoS One. 2019;14:e0218186.
    >> Share

  312. YI H, Cai B, Ai X, Liu R, et al
    Value of contrast-enhanced ultrasound for preoperative assessment of liver reserve function in patients with liver tumors.
    PLoS One. 2019;14:e0222514.
    >> Share

  313. KOIZUMI Y, Hirooka M, Tamaki N, Yada N, et al
    New diagnostic technique to evaluate hepatic steatosis using the attenuation coefficient on ultrasound B mode.
    PLoS One. 2019;14:e0221548.
    >> Share

  314. LEE SM, Kim BJ, Koo JN, Norwitz ER, et al
    Nonalcoholic fatty liver disease is a risk factor for large-for-gestational-age birthweight.
    PLoS One. 2019;14:e0221400.
    >> Share

  315. PFLUGRAD H, Tryc AB, Goldbecker A, Barg-Hock H, et al
    Cerebral metabolite alterations in patients with posttransplant encephalopathy after liver transplantation.
    PLoS One. 2019;14:e0221626.
    >> Share

  316. WAGNER J, Fillebeen C, Haliotis T, Charlebois E, et al
    Mouse models of hereditary hemochromatosis do not develop early liver fibrosis in response to a high fat diet.
    PLoS One. 2019;14:e0221455.
    >> Share

  317. ZHANG T, Runge JH, Lavini C, Stoker J, et al
    A pharmacokinetic model including arrival time for two inputs and compensating for varying applied flip-angle in dynamic gadoxetic acid-enhanced MR imaging.
    PLoS One. 2019;14:e0220835.
    >> Share

  318. KAIBORI M, Matsui K, Yoshii K, Ishizaki M, et al
    Perioperative exercise capacity in chronic liver injury patients with hepatocellular carcinoma undergoing hepatectomy.
    PLoS One. 2019;14:e0221079.
    >> Share

  319. PARK MR, Wong MS, Arauzo-Bravo MJ, Lee H, et al
    Oct4 and Hnf4alpha-induced hepatic stem cells ameliorate chronic liver injury in liver fibrosis model.
    PLoS One. 2019;14:e0221085.
    >> Share

  320. KIMMANN M, Tergast TL, Schultalbers M, Laser H, et al
    Sustained impact of nosocomial-acquired spontaneous bacterial peritonitis in different stages of decompensated liver cirrhosis.
    PLoS One. 2019;14:e0220666.
    >> Share

  321. LIN YM, Chiou YY, Wu MH, Huang SS, et al
    Postablation assessment of hepatocellular carcinoma using dual-energy CT: Comparison of half versus standard iodine contrast medium.
    PLoS One. 2019;14:e0219577.
    >> Share

  322. LI L, Shi M, Salerno S, Tang M, et al
    Microbial and metabolomic remodeling by a formula of Sichuan dark tea improves hyperlipidemia in apoE-deficient mice.
    PLoS One. 2019;14:e0219010.
    >> Share

  323. QUECK A, Thomas D, Jansen C, Schreiber Y, et al
    Pathophysiological role of prostanoids in coagulation of the portal venous system in liver cirrhosis.
    PLoS One. 2019;14:e0222840.
    >> Share

  324. ZHANG BH, Li B, Kong LX, Yan LN, et al
    Diagnostic accuracy of midkine on hepatocellular carcinoma: A meta-analysis.
    PLoS One. 2019;14:e0223514.
    >> Share

  325. BROCK GN, Washburn K, Marvin MR
    Use of rapid Model for End-Stage Liver Disease (MELD) increases for liver transplant registrant prioritization after MELD-Na and Share 35, an evaluation using data from the United Network for Organ Sharing.
    PLoS One. 2019;14:e0223053.
    >> Share

  326. BERNI ER, Jones BI, Berni TR, Whitehouse J, et al
    The Model of Mortality with Incident Cirrhosis (MoMIC) and the model of Long-term Outlook of Mortality in Cirrhosis (LOMiC).
    PLoS One. 2019;14:e0223253.
    >> Share

  327. ZHAO Y, Zhang Y, Vazirinejad Mehdiabad M, Zhou K, et al
    Enhanced anti-tumor effect of liposomal Fasudil on hepatocellular carcinoma in vitro and in vivo.
    PLoS One. 2019;14:e0223232.
    >> Share

  328. OUD L
    In-hospital cardiopulmonary resuscitation of patients with cirrhosis: A population-based analysis.
    PLoS One. 2019;14:e0222873.
    >> Share

  329. NAVARRO VJ, Belle SH, D'Amato M, Adfhal N, et al
    Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial.
    PLoS One. 2019;14:e0221683.
    >> Share

  330. SONG SK, Jung WY, Park SK, Chung CW, et al
    Significantly different expression levels of microRNAs associated with vascular invasion in hepatocellular carcinoma and their prognostic significance after surgical resection.
    PLoS One. 2019;14:e0216847.
    >> Share

  331. ZHANG J, Zhao Z, Bai H, Wang M, et al
    Genetic polymorphisms in PXR and NF-kappaB1 influence susceptibility to anti-tuberculosis drug-induced liver injury.
    PLoS One. 2019;14:e0222033.
    >> Share

  332. KAUR H, Bhalla S, Raghava GPS
    Classification of early and late stage liver hepatocellular carcinoma patients from their genomics and epigenomics profiles.
    PLoS One. 2019;14:e0221476.
    >> Share

  333. TEREFE TESFAYE B, Gudina EK, Bosho DD, Mega TA, et al
    Short-term clinical outcomes of patients admitted with chronic liver disease to selected teaching hospitals in Ethiopia.
    PLoS One. 2019;14:e0221806.
    >> Share

  334. WARGNY M, Smati S, Pichelin M, Bigot-Corbel E, et al
    Fatty liver index is a strong predictor of changes in glycemic status in people with prediabetes: The IT-DIAB study.
    PLoS One. 2019;14:e0221524.
    >> Share

  335. VAN DEN BERG EH, Corsetti JP, Bakker SJL, Dullaart RPF, et al
    Plasma ApoE elevations are associated with NAFLD: The PREVEND Study.
    PLoS One. 2019;14:e0220659.
    >> Share

  336. WONG RJ, Tran T, Kaufman H, Niles J, et al
    Increasing metabolic co-morbidities are associated with higher risk of advanced fibrosis in nonalcoholic steatohepatitis.
    PLoS One. 2019;14:e0220612.
    >> Share

  337. GERHARD GS, Hanson A, Wilhelmsen D, Piras IS, et al
    AEBP1 expression increases with severity of fibrosis in NASH and is regulated by glucose, palmitate, and miR-372-3p.
    PLoS One. 2019;14:e0219764.
    >> Share

  338. CHOI C, Son A, Lee GH, Shin SW, et al
    Targeting DNA-dependent protein kinase sensitizes hepatocellular carcinoma cells to proton beam irradiation through apoptosis induction.
    PLoS One. 2019;14:e0218049.
    >> Share

  339. RENNERT J, Wiesinger I, Schicho A, Beyer LP, et al
    Color coded perfusion imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following trans-arterial chemoembolization (TACE) of hepatocellular carcinoma.
    PLoS One. 2019;14:e0217599.
    >> Share

  340. OLDANI G, Peloso A, Slits F, Gex Q, et al
    The impact of short-term machine perfusion on the risk of cancer recurrence after rat liver transplantation with donors after circulatory death.
    PLoS One. 2019;14:e0224890.
    >> Share

  341. ARAI T, Atsukawa M, Tsubota A, Kawano T, et al
    Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease.
    PLoS One. 2019;14:e0224184.
    >> Share

  342. SEMMLER G, Scheiner B, Schwabl P, Bucsics T, et al
    The impact of hepatic steatosis on portal hypertension.
    PLoS One. 2019;14:e0224506.
    >> Share

  343. NIRIELLA MA, Kasturiratna A, Beddage T, Ediriweera DS, et al
    Non-resolution of non-alcoholic fatty liver disease (NAFLD) among urban, adult Sri Lankans in the general population: A prospective, cohort follow-up study.
    PLoS One. 2019;14:e0224474.
    >> Share

  344. CHUANG PY, Yang TY, Huang TW, Tsai YH, et al
    Hepatic disease and the risk of mortality of Vibrio vulnificus necrotizing skin and soft tissue infections: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0223513.
    >> Share

  345. MARTINEZ-HERRERO MDC, Garijo-Toledo MM, Gonzalez F, Bilic I, et al
    Membrane associated proteins of two Trichomonas gallinae clones vary with the virulence.
    PLoS One. 2019;14:e0224032.
    >> Share

  346. FOLADOR L, Torres FS, Zampieri JF, Machado BC, et al
    Hepatopulmonary syndrome has low prevalence of pulmonary vascular abnormalities on chest computed tomography.
    PLoS One. 2019;14:e0223805.
    >> Share

  347. KIM BK, Kim DY, Han KH, Seong J, et al
    Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample study.
    PLoS One. 2019;14:e0223678.
    >> Share

  348. DING W, Tan Y, Qian Y, Xue W, et al
    Clinicopathologic and prognostic significance of tumor-associated macrophages in patients with hepatocellular carcinoma: A meta-analysis.
    PLoS One. 2019;14:e0223971.
    >> Share

  349. KAYS JK, Milgrom DP, Butler JR, Liang TW, et al
    Specialized care improves outcomes for patients with cirrhosis who require general surgical operations.
    PLoS One. 2019;14:e0223454.
    >> Share

  350. WU VC, Chen SW, Chou AH, Ting PC, et al
    Dual antiplatelet therapy in patients with cirrhosis and acute myocardial infarction - A 13-year nationwide cohort study.
    PLoS One. 2019;14:e0223380.
    >> Share

  351. HIGARZA SG, Arboleya S, Gueimonde M, Gomez-Lazaro E, et al
    Neurobehavioral dysfunction in non-alcoholic steatohepatitis is associated with hyperammonemia, gut dysbiosis, and metabolic and functional brain regional deficits.
    PLoS One. 2019;14:e0223019.
    >> Share

  352. SAEKI I, Yamasaki T, Maeda M, Hisanaga T, et al
    Effect of body composition on survival benefit of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: A comparison with sorafenib therapy.
    PLoS One. 2019;14:e0218136.
    >> Share

  353. WERNBERG CW, Schaffalitzky de Muckadell OB, Vilstrup H, M Lauridsen M, et al
    Prediction of overt hepatic encephalopathy by the continuous reaction time method and the portosystemic encephalopathy syndrome test in clinically mentally unimpaired patients with cirrhosis.
    PLoS One. 2019;14:e0226283.
    >> Share

  354. KATO S, Iwasaki A, Kurita Y, Arimoto J, et al
    Three-dimensional analysis of pancreatic fat by fat-water magnetic resonance imaging provides detailed characterization of pancreatic steatosis with improved reproducibility.
    PLoS One. 2019;14:e0224921.
    >> Share

  355. FU CP, Ali H, Rachakonda VP, Oczypok EA, et al
    The ZJU index is a powerful surrogate marker for NAFLD in severely obese North American women.
    PLoS One. 2019;14:e0224942.
    >> Share

  356. KONNO R, Tatebe S, Sugimura K, Satoh K, et al
    Prognostic value of the model for end-stage liver disease excluding INR score (MELD-XI) in patients with adult congenital heart disease.
    PLoS One. 2019;14:e0225403.
    >> Share

  357. LOHOFER FK, Kaissis GA, Muller-Leisse C, Franz D, et al
    Acceleration of chemical shift encoding-based water fat MRI for liver proton density fat fraction and T2* mapping using compressed sensing.
    PLoS One. 2019;14:e0224988.
    >> Share

  358. YANG M, Zhang X, Liu J
    Prognostic value of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma treated with transarterial chemotherapy: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0225170.
    >> Share

  359. YUAN WH, Li AF, Hsu HC, Hu YS, et al
    Initial clinical radiological findings and staging to predict prognosis of primary hepatic angiosarcoma: A retrospective analysis.
    PLoS One. 2019;14:e0225043.
    >> Share

  360. ERHARTOVA D, Cahova M, Dankova H, Heczkova M, et al
    Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation.
    PLoS One. 2019;14:e0224820.
    >> Share

  361. GROENER JB, Valkanou A, Kender Z, Pfeiffenberger J, et al
    Asprosin response in hypoglycemia is not related to hypoglycemia unawareness but rather to insulin resistance in type 1 diabetes.
    PLoS One. 2019;14:e0222771.
    >> Share

  362. GARNAES E, Mortensen C, Hobolth L, Andersen O, et al
    Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis.
    PLoS One. 2019;14:e0220697.
    >> Share

  363. HOWELL AK, McCann CM, Wickstead F, Williams DJL, et al
    Co-infection of cattle with Fasciola hepatica or F. gigantica and Mycobacterium bovis: A systematic review.
    PLoS One. 2019;14:e0226300.
    >> Share

  364. SUDJARITRUK T, Bunupuradah T, Aurpibul L, Kosalaraksa P, et al
    Nonalcoholic fatty liver disease and hepatic fibrosis among perinatally HIV-monoinfected Asian adolescents receiving antiretroviral therapy.
    PLoS One. 2019;14:e0226375.
    >> Share

  365. ERKAN B, Meier J, Clark TJ, Kaplan J, et al
    Non-invasive diagnostic criteria of hepatocellular carcinoma: Comparison of diagnostic accuracy of updated LI-RADS with clinical practice guidelines of OPTN-UNOS, AASLD, NCCN, EASL-EORTC, and KLSCG-NCC.
    PLoS One. 2019;14:e0226291.
    >> Share

  366. ABBASS MA, Ahmad SA, Mahalingam N, Krothapalli KS, et al
    In vivo ultrasound thermal ablation control using echo decorrelation imaging in rabbit liver and VX2 tumor.
    PLoS One. 2019;14:e0226001.
    >> Share

  367. SU RC, Lad A, Breidenbach JD, Blomquist TM, et al
    Hyperglycemia induces key genetic and phenotypic changes in human liver epithelial HepG2 cells which parallel the Leprdb/J mouse model of non-alcoholic fatty liver disease (NAFLD).
    PLoS One. 2019;14:e0225604.
    >> Share

  368. ZHONG GC, Liu S, Wu YL, Xia M, et al
    ABO blood group and risk of newly diagnosed nonalcoholic fatty liver disease: A case-control study in Han Chinese population.
    PLoS One. 2019;14:e0225792.
    >> Share

  369. SCOTT C, Stokes R, Cha KM, Clouston A, et al
    Myeloid cell deletion of Aryl hydrocarbon Receptor Nuclear Translocator (ARNT) induces non-alcoholic steatohepatitis.
    PLoS One. 2019;14:e0225332.
    >> Share

  370. WELDEAREGAY KT, Gebrekidan MG, Gezahegne AA
    Health impact of hepatic-venous-occlusive disease in a small town in Ethiopia-Case study from Tahtay koraro district in Tigray region, 2017.
    PLoS One. 2019;14:e0224659.
    >> Share

  371. SENDRA L, Herrero MJ, Montalva EM, Noguera I, et al
    Efficacy of interleukin 10 gene hydrofection in pig liver vascular isolated 'in vivo' by surgical procedure with interest in liver transplantation.
    PLoS One. 2019;14:e0224568.
    >> Share

  372. YANG S, Kwak S, Lee JH, Kang S, et al
    Nonalcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population.
    PLoS One. 2019;14:e0224626.
    >> Share

  373. BUCHER JN, Koenig M, Schoenberg MB, Crispin A, et al
    Liver transplantation in patients with a history of migration-A German single center comparative analysis.
    PLoS One. 2019;14:e0224116.
    >> Share

  374. BAJAJ JS, Fan S, Thacker LR, Fagan A, et al
    Serum and urinary metabolomics and outcomes in cirrhosis.
    PLoS One. 2019;14:e0223061.
    >> Share

  375. ISHIKAWA T, Sasaki R, Nishimura T, Aibe Y, et al
    A novel therapeutic strategy for esophageal varices using endoscopic treatment combined with splenic artery embolization according to the Child-Pugh classification.
    PLoS One. 2019;14:e0223153.
    >> Share

  376. LIU Y, Liu X, Wang Y, Yi C, et al
    Protective effect of lactobacillus plantarum on alcoholic liver injury and regulating of keap-Nrf2-ARE signaling pathway in zebrafish larvae.
    PLoS One. 2019;14:e0222339.
    >> Share

  377. LEVICK C, Phillips-Hughes J, Collier J, Banerjee R, et al
    Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: A proof of concept study.
    PLoS One. 2019;14:e0221066.
    >> Share

  378. MIN-DEBARTOLO J, Schlerman F, Akare S, Wang J, et al
    Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH).
    PLoS One. 2019;14:e0226854.
    >> Share

    January 2018
  379. SHI T, Yang X, Zhou H, Xi J, et al
    Activated carbon N-acetylcysteine microcapsule protects against nonalcoholic fatty liver disease in young rats via activating telomerase and inhibiting apoptosis.
    PLoS One. 2018;13:e0189856.
    >> Share

  380. BUCSICS T, Schoder M, Diermayr M, Feldner-Busztin M, et al
    Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experience.
    PLoS One. 2018;13:e0189414.
    >> Share

  381. XU R, Jiang YF, Zhang YH, Yang X, et al
    The optimal threshold of serum ceruloplasmin in the diagnosis of Wilson's disease: A large hospital-based study.
    PLoS One. 2018;13:e0190887.
    >> Share

  382. SARACINO A, Cozzi-Lepri A, Shanyinde M, Ceccherini Silberstein F, et al
    HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients.
    PLoS One. 2018;13:e0190302.
    >> Share

  383. WANG TH, Huang PI, Hu YW, Lin KH, et al
    Combined Yttrium-90 microsphere selective internal radiation therapy and external beam radiotherapy in patients with hepatocellular carcinoma: From clinical aspects to dosimetry.
    PLoS One. 2018;13:e0190098.
    >> Share

  384. CHEN WT, Lin GB, Lin SH, Lu CH, et al
    Static magnetic field enhances the anticancer efficacy of capsaicin on HepG2 cells via capsaicin receptor TRPV1.
    PLoS One. 2018;13:e0191078.
    >> Share

  385. HUANG Z, Huang J, Zhou T, Cao H, et al
    Prognostic value of liver stiffness measurement for the liver-related surgical outcomes of patients under hepatic resection: A meta-analysis.
    PLoS One. 2018;13:e0190512.
    >> Share

  386. CHOI YJ, Park SJ, Park YS, Park HS, et al
    EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells.
    PLoS One. 2018;13:e0190638.
    >> Share

  387. MULABECIROVIC A, Mjelle AB, Gilja OH, Vesterhus M, et al
    Repeatability of shear wave elastography in liver fibrosis phantoms-Evaluation of five different systems.
    PLoS One. 2018;13:e0189671.
    >> Share

  388. KAWAGUCHI T, Shima T, Mizuno M, Mitsumoto Y, et al
    Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers.
    PLoS One. 2018;13:e0185490.
    >> Share

  389. TESHIMA T, Matsumoto H, Koyama H
    Soluble factors from adipose tissue-derived mesenchymal stem cells promote canine hepatocellular carcinoma cell proliferation and invasion.
    PLoS One. 2018;13:e0191539.
    >> Share

  390. PAPACKOVA Z, Heczkova M, Dankova H, Sticova E, et al
    Silymarin prevents acetaminophen-induced hepatotoxicity in mice.
    PLoS One. 2018;13:e0191353.
    >> Share

  391. OTEGBEYE F, Ojo E, Moreton S, Mackowski N, et al
    Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models.
    PLoS One. 2018;13:e0191358.
    >> Share

  392. HE X, Wu J, Holtorf AP, Rinde H, et al
    Health economic assessment of Gd-EOB-DTPA MRI versus ECCM-MRI and multi-detector CT for diagnosis of hepatocellular carcinoma in China.
    PLoS One. 2018;13:e0191095.
    >> Share

  393. GONG L, Huang YT, Wong CH, Chao WC, et al
    Culture-independent analysis of liver abscess using nanopore sequencing.
    PLoS One. 2018;13:e0190853.
    >> Share

  394. BENMASSAOUD A, Ghali P, Cox J, Wong P, et al
    Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection.
    PLoS One. 2018;13:e0191985.
    >> Share

  395. NARAN NH, Haagensen M, Crowther NJ
    Steatosis in South African women: How much and why?
    PLoS One. 2018;13:e0191388.
    >> Share

  396. FERRIGNO A, Di Pasqua LG, Berardo C, Siciliano V, et al
    The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury.
    PLoS One. 2018;13:e0191430.
    >> Share

  397. YAMADA K, Mizukoshi E, Seike T, Horii R, et al
    Light alcohol consumption has the potential to suppress hepatocellular injury and liver fibrosis in non-alcoholic fatty liver disease.
    PLoS One. 2018;13:e0191026.
    >> Share

  398. LIANG DY, Huang W, Chang Q, Hou YQ, et al
    ShDcR3 sensitizes TRAIL-resistant HCC cells by inducing caspase-dependent apoptosis while suppressing NF-kappaB dependent cFLIPL expression.
    PLoS One. 2018;13:e0191545.
    >> Share

  399. LE CT, Nguyen G, Park SY, Choi DH, et al
    LY2405319, an analog of fibroblast growth factor 21 ameliorates alpha-smooth muscle actin production through inhibition of the succinate-G-protein couple receptor 91 (GPR91) pathway in mice.
    PLoS One. 2018;13:e0192146.
    >> Share

  400. CHANG W, Lee JM, Lee DH, Yoon JH, et al
    Comparison of switching bipolar ablation with multiple cooled wet electrodes and switching monopolar ablation with separable clustered electrode in treatment of small hepatocellular carcinoma: A randomized controlled trial.
    PLoS One. 2018;13:e0192173.
    >> Share

  401. MAIOLI M, Basoli V, Carta P, Fabbri D, et al
    Synthesis of magnolol and honokiol derivatives and their effect against hepatocarcinoma cells.
    PLoS One. 2018;13:e0192178.
    >> Share

  402. RAUBER P, Lammert F, Grotemeyer K, Appenrodt B, et al
    Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study.
    PLoS One. 2018;13:e0192271.
    >> Share

  403. GONZALEZ-CANTERO J, Martin-Rodriguez JL, Gonzalez-Cantero A, Arrebola JP, et al
    Insulin resistance in lean and overweight non-diabetic Caucasian adults: Study of its relationship with liver triglyceride content, waist circumference and BMI.
    PLoS One. 2018;13:e0192663.
    >> Share

  404. YANG C, Yang S, Feng C, Zhang C, et al
    Associations of hyperuricemia and obesity with remission of nonalcoholic fatty liver disease among Chinese men: A retrospective cohort study.
    PLoS One. 2018;13:e0192396.
    >> Share

  405. PRAKTIKNJO M, Krabbe V, Pohlmann A, Sampels M, et al
    Evolution of nodule stiffness might predict response to local ablative therapy: A series of patients with hepatocellular carcinoma.
    PLoS One. 2018;13:e0192897.
    >> Share

  406. EBERHARDT C, Wurnig MC, Wirsching A, Rossi C, et al
    Prediction of small for size syndrome after extended hepatectomy: Tissue characterization by relaxometry, diffusion weighted magnetic resonance imaging and magnetization transfer.
    PLoS One. 2018;13:e0192847.
    >> Share

  407. PACHIKIAN BD, Druart C, Catry E, Bindels LB, et al
    Implication of trans-11,trans-13 conjugated linoleic acid in the development of hepatic steatosis.
    PLoS One. 2018;13:e0192447.
    >> Share

  408. YETTI H, Naito H, Yuan Y, Jia X, et al
    Bile acid detoxifying enzymes limit susceptibility to liver fibrosis in female SHRSP5/Dmcr rats fed with a high-fat-cholesterol diet.
    PLoS One. 2018;13:e0192863.
    >> Share

  409. ROMERO-IBARGUENGOITIA ME, Vadillo-Ortega F, Caballero AE, Ibarra-Gonzalez I, et al
    Family history and obesity in youth, their effect on acylcarnitine/aminoacids metabolomics and non-alcoholic fatty liver disease (NAFLD). Structural equation modeling approach.
    PLoS One. 2018;13:e0193138.
    >> Share

  410. KAKOSCHKY B, Pleli T, Schmithals C, Zeuzem S, et al
    Selective targeting of tumor associated macrophages in different tumor models.
    PLoS One. 2018;13:e0193015.
    >> Share

  411. SZYMCZAK M, Kalicinski P, Kowalewski G, Broniszczak D, et al
    Acute liver failure in children-Is living donor liver transplantation justified?
    PLoS One. 2018;13:e0193327.
    >> Share

  412. LEE JE, Lee YJ, Chung SY, Cho HW, et al
    Severity of nonalcoholic fatty liver disease is associated with subclinical cerebro-cardiovascular atherosclerosis risk in Korean men.
    PLoS One. 2018;13:e0193191.
    >> Share

  413. CHRISTENSEN CU, Glavind E, Thomsen KL, Kim YO, et al
    Niemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease.
    PLoS One. 2018;13:e0192728.
    >> Share

  414. HOF J, Joosten HJ, Havenga K, de Jong KP, et al
    Radiofrequency ablation is beneficial in simultaneous treatment of synchronous liver metastases and primary colorectal cancer.
    PLoS One. 2018;13:e0193385.
    >> Share

  415. MAYR U, Karsten E, Lahmer T, Rasch S, et al
    Impact of large volume paracentesis on respiratory parameters including transpulmonary pressure and on transpulmonary thermodilution derived hemodynamics: A prospective study.
    PLoS One. 2018;13:e0193654.
    >> Share

  416. ZEKRI AN, El-Sisi ER, Youssef ASE, Kamel MM, et al
    MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection.
    PLoS One. 2018;13:e0193709.
    >> Share

  417. LUO L, Aubrecht J, Li D, Warner RL, et al
    Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans.
    PLoS One. 2018;13:e0193824.
    >> Share

  418. WATTANAVANITCHAKORN S, Rojvirat P, Chavalit T, MacDonald MJ, et al
    CCAAT-enhancer binding protein-alpha (C/EBPalpha) and hepatocyte nuclear factor 4alpha (HNF4alpha) regulate expression of the human fructose-1,6-bisphosphatase 1 (FBP1) gene in human hepatocellular carcinoma HepG2 cells.
    PLoS One. 2018;13:e0194252.
    >> Share

  419. HEMMINGER J, Arole V, Ayoub I, Brodsky SV, et al
    Acute glomerulonephritis with large confluent IgA-dominant deposits associated with liver cirrhosis.
    PLoS One. 2018;13:e0193274.
    >> Share

  420. TANNUS RK, Almeida-Carvalho SR, Loureiro-Matos CA, Miziara-Gonzalez A, et al
    Evaluation of survival of patients with hepatocellular carcinoma: A comparative analysis of prognostic systems.
    PLoS One. 2018;13:e0194922.
    >> Share

  421. SHAHEEN AA, Kaplan GG, Almishri W, Vallerand I, et al
    The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes.
    PLoS One. 2018;13:e0194839.
    >> Share

  422. BIAN S, Chen H, Wang L, Fei Y, et al
    Cardiac involvement in patients with primary biliary cholangitis: A 14-year longitudinal survey-based study.
    PLoS One. 2018;13:e0194397.
    >> Share

  423. LIAO CY, Chung CH, Chu P, Wei KY, et al
    Increased risk of osteoporosis in patients with primary biliary cirrhosis.
    PLoS One. 2018;13:e0194418.
    >> Share

  424. ALEXANDER KS, Zakai NA, Lidofsky SD, Callas PW, et al
    Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohort.
    PLoS One. 2018;13:e0194153.
    >> Share

  425. KELLER S, Aigner A, Zenouzi R, Kim AC, et al
    Association of gadolinium-enhanced magnetic resonance imaging with hepatic fibrosis and inflammation in primary sclerosing cholangitis.
    PLoS One. 2018;13:e0193929.
    >> Share

  426. JANSEN C, Al-Kassou B, Lehmann J, Pohlmann A, et al
    Severe abnormal Heart Rate Turbulence Onset is associated with deterioration of liver cirrhosis.
    PLoS One. 2018;13:e0195631.
    >> Share

  427. HONDA F, Hiramatsu A, Hyogo H, Aikata H, et al
    Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoring.
    PLoS One. 2018;13:e0195028.
    >> Share

  428. CHENG YL, Shu JH, Hsu HC, Liang Y, et al
    High health literacy is associated with less obesity and lower Framingham risk score: Sub-study of the VGH-HEALTHCARE trial.
    PLoS One. 2018;13:e0194813.
    >> Share

  429. ONICIU DC, Hashiguchi T, Shibazaki Y, Bisgaier CL, et al
    Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM model of NASH.
    PLoS One. 2018;13:e0194568.
    >> Share

  430. PARK IK, Yu JS, Cho ES, Kim JH, et al
    Apparent diffusion coefficient of hepatocellular carcinoma on diffusion-weighted imaging: Histopathologic tumor grade versus arterial vascularity during dynamic magnetic resonance imaging.
    PLoS One. 2018;13:e0197070.
    >> Share

  431. YUAN LT, Chuah SK, Yang SC, Liang CM, et al
    Multiple bacterial infections increase the risk of hepatic encephalopathy in patients with cirrhosis.
    PLoS One. 2018;13:e0197127.
    >> Share

  432. AXLEY P, Mudumbi S, Sarker S, Kuo YF, et al
    Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications.
    PLoS One. 2018;13:e0197117.
    >> Share

  433. MAK D, Babb de Villiers C, Chasela C, Urban MI, et al
    Analysis of risk factors associated with hepatocellular carcinoma in black South Africans: 2000-2012.
    PLoS One. 2018;13:e0196057.
    >> Share

  434. ZHANG B, Chen M, Zhang Y, Chen W, et al
    An ultrasonic nanobubble-mediated PNP/fludarabine suicide gene system: A new approach for the treatment of hepatocellular carcinoma.
    PLoS One. 2018;13:e0196686.
    >> Share

  435. SU YB, Li TH, Huang CC, Tsai HC, et al
    Chronic calcitriol supplementation improves the inflammatory profiles of circulating monocytes and the associated intestinal/adipose tissue alteration in a diet-induced steatohepatitis rat model.
    PLoS One. 2018;13:e0194867.
    >> Share

  436. OKAMOTO M, Miyake T, Kitai K, Furukawa S, et al
    Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: A longitudinal cohort study.
    PLoS One. 2018;13:e0195147.
    >> Share

  437. BONNET E, Moutet ML, Baulard C, Bacq-Daian D, et al
    Performance comparison of three DNA extraction kits on human whole-exome data from formalin-fixed paraffin-embedded normal and tumor samples.
    PLoS One. 2018;13:e0195471.
    >> Share

  438. FRICKE IB, De Souza R, Costa Ayub L, Francia G, et al
    Spatiotemporal assessment of spontaneous metastasis formation using multimodal in vivo imaging in HER2+ and triple negative metastatic breast cancer xenograft models in mice.
    PLoS One. 2018;13:e0196892.
    >> Share

  439. DUTTA S, Chakraborty AK, Dey P, Kar P, et al
    Amelioration of CCl4 induced liver injury in swiss albino mice by antioxidant rich leaf extract of Croton bonplandianus Baill.
    PLoS One. 2018;13:e0196411.
    >> Share

  440. REITER R, Wetzel M, Hamesch K, Strnad P, et al
    Comparison of non-invasive assessment of liver fibrosis in patients with alpha1-antitrypsin deficiency using magnetic resonance elastography (MRE), acoustic radiation force impulse (ARFI) Quantification, and 2D-shear wave elastography (2D-SWE).
    PLoS One. 2018;13:e0196486.
    >> Share

  441. OFFOR O, Utay N, Reynoso D, Somasunderam A, et al
    Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy.
    PLoS One. 2018;13:e0196395.
    >> Share

  442. KROHN S, Zeller K, Bohm S, Chatzinotas A, et al
    Molecular quantification and differentiation of Candida species in biological specimens of patients with liver cirrhosis.
    PLoS One. 2018;13:e0197319.
    >> Share

  443. TINGUELY P, Schwalbe M, Fuss T, Guensch DP, et al
    Multi-Operational Selective Computer-Assisted Targeting of hepatocellular carcinoma-Evaluation of a novel approach for navigated tumor ablation.
    PLoS One. 2018;13:e0197914.
    >> Share

  444. ZHAO W, Liu W, Liu H, Yi X, et al
    Preoperative prediction of microvascular invasion of hepatocellular carcinoma with IVIM diffusion-weighted MR imaging and Gd-EOB-DTPA-enhanced MR imaging.
    PLoS One. 2018;13:e0197488.
    >> Share

  445. KALMAN R, Stawarz A, Nunes D, Zhang D, et al
    Biophotonic detection of high order chromatin alterations in field carcinogenesis predicts risk of future hepatocellular carcinoma: A pilot study.
    PLoS One. 2018;13:e0197427.
    >> Share

  446. SETHUNATH D, Morusu S, Tuceryan M, Cummings OW, et al
    Automated assessment of steatosis in murine fatty liver.
    PLoS One. 2018;13:e0197242.
    >> Share

  447. UMEHARA T
    Nonalcoholic fatty liver disease with elevated alanine aminotransferase levels is negatively associated with bone mineral density: Cross-sectional study in U.S. adults.
    PLoS One. 2018;13:e0197900.
    >> Share

  448. WANG HW, Shi HN, Cheng J, Xie F, et al
    Real-time shear wave elastography (SWE) assessment of short- and long-term treatment outcome in Budd-Chiari syndrome: A pilot study.
    PLoS One. 2018;13:e0197550.
    >> Share

  449. MILLINGS EJ, De Rosa MC, Fleet S, Watanabe K, et al
    ILDR2 has a negligible role in hepatic steatosis.
    PLoS One. 2018;13:e0197548.
    >> Share

  450. LUDWIG JM, Zhang Y, Chamulitrat W, Stremmel W, et al
    Anti-inflammatory properties of ursodeoxycholyl lysophosphatidylethanolamide in endotoxin-mediated inflammatory liver injury.
    PLoS One. 2018;13:e0197836.
    >> Share

  451. CALLE RUBIO M, Soriano JB, Lopez-Campos JL, Soler-Cataluna JJ, et al
    Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study.
    PLoS One. 2018;13:e0198777.
    >> Share

  452. TSAI WC, Kung PT, Wang YH, Kuo WY, et al
    Influence of the time interval from diagnosis to treatment on survival for early-stage liver cancer.
    PLoS One. 2018;13:e0199532.
    >> Share

  453. CHANG PE, Goh GBB, Leow WQ, Shen L, et al
    Second harmonic generation microscopy provides accurate automated staging of liver fibrosis in patients with non-alcoholic fatty liver disease.
    PLoS One. 2018;13:e0199166.
    >> Share

  454. BHATT SP, Guleria R, Vikram NK, Nandhan SV, et al
    Association of inflammatory genes in obstructive sleep apnea and non alcoholic fatty liver disease in Asian Indians residing in north India.
    PLoS One. 2018;13:e0199599.
    >> Share

  455. OBMANN VC, Mertineit N, Berzigotti A, Marx C, et al
    CT predicts liver fibrosis: Prospective evaluation of morphology- and attenuation-based quantitative scores in routine portal venous abdominal scans.
    PLoS One. 2018;13:e0199611.
    >> Share

  456. HWANG A, Shi C, Zhu E, Naaz F, et al
    Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASH.
    PLoS One. 2018;13:e0198937.
    >> Share

  457. TAKADA H, Kurosaki M, Nakanishi H, Takahashi Y, et al
    Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma.
    PLoS One. 2018;13:e0198812.
    >> Share

  458. CHEN CT, Lee HL, Chiou HL, Chou CH, et al
    Impacts of WNT1-inducible signaling pathway protein 1 polymorphism on hepatocellular carcinoma development.
    PLoS One. 2018;13:e0198967.
    >> Share

  459. SATSANGI S, Duseja A, Sachdeva M, Tomer S, et al
    Monocyte human leukocyte antigen - Antigen D related, neutrophil oxidative burst and cytokine analysis in patients of decompensated cirrhosis with and without acute-on chronic liver failure.
    PLoS One. 2018;13:e0200644.
    >> Share

  460. CRESSMAN ENK, Guo C, Karbasian N
    Image-guided chemistry altering biology: An in vivo study of thermoembolization.
    PLoS One. 2018;13:e0200471.
    >> Share

  461. CHOI BH, Jin Z, Yi CO, Oh J, et al
    Effects of lobeglitazone on insulin resistance and hepatic steatosis in high-fat diet-fed mice.
    PLoS One. 2018;13:e0200336.
    >> Share

  462. DALVI PS, Yang S, Swain N, Kim J, et al
    Long-term metabolic effects of malnutrition: Liver steatosis and insulin resistance following early-life protein restriction.
    PLoS One. 2018;13:e0199916.
    >> Share

  463. UCHINO K, Tateishi R, Nakagomi R, Fujiwara N, et al
    Serum levels of ferritin do not affect the prognosis of patients with hepatocellular carcinoma undergoing radiofrequency ablation.
    PLoS One. 2018;13:e0200943.
    >> Share

  464. RINGE KI, von Falck C, Raatschen HJ, Wacker F, et al
    Evaluation of transient respiratory motion artifact at gadoxetate disodium-enhanced MRI-Influence of different contrast agent application protocols.
    PLoS One. 2018;13:e0200887.
    >> Share

  465. LIMA JG, Nobrega LHC, Lima NN, Dos Santos MCF, et al
    Causes of death in patients with Berardinelli-Seip congenital generalized lipodystrophy.
    PLoS One. 2018;13:e0199052.
    >> Share

  466. WANG X, Kwak KJ, Yang Z, Zhang A, et al
    Extracellular mRNA detected by molecular beacons in tethered lipoplex nanoparticles for diagnosis of human hepatocellular carcinoma.
    PLoS One. 2018;13:e0198552.
    >> Share

  467. JARZABEK MA, Proctor WR, Vogt J, Desai R, et al
    Interrogation of transcriptomic changes associated with drug-induced hepatic sinusoidal dilatation in colorectal cancer.
    PLoS One. 2018;13:e0198099.
    >> Share

  468. NA SK, Choi GH, Lee HC, Shin YM, et al
    The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection.
    PLoS One. 2018;13:e0198138.
    >> Share

  469. FRANCH-NADAL J, Caballeria L, Mata-Cases M, Mauricio D, et al
    Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study.
    PLoS One. 2018;13:e0198327.
    >> Share

  470. SUN S, Hanzawa F, Umeki M, Ikeda S, et al
    Time-restricted feeding suppresses excess sucrose-induced plasma and liver lipid accumulation in rats.
    PLoS One. 2018;13:e0201261.
    >> Share

  471. EYRAUD D, Suner L, Dupont A, Bachelot-Loza C, et al
    Evolution of platelet functions in cirrhotic patients undergoing liver transplantation: A prospective exploration over a month.
    PLoS One. 2018;13:e0200364.
    >> Share

  472. TANG Y, Blomenkamp KS, Fickert P, Trauner M, et al
    NorUDCA promotes degradation of alpha1-antitrypsin mutant Z protein by inducing autophagy through AMPK/ULK1 pathway.
    PLoS One. 2018;13:e0200897.
    >> Share

  473. BOTEON YL, Wallace L, Boteon APCS, Mirza DF, et al
    An effective protocol for pharmacological defatting of primary human hepatocytes which is non-toxic to cholangiocytes or intrahepatic endothelial cells.
    PLoS One. 2018;13:e0201419.
    >> Share

  474. SENDI H, Mead I, Wan M, Mehrab-Mohseni M, et al
    miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling.
    PLoS One. 2018;13:e0200847.
    >> Share

  475. COZZI L, Comito T, Fogliata A, Franzese C, et al
    Critical appraisal of the potential role of intensity modulated proton therapy in the hypofractionated treatment of advanced hepatocellular carcinoma.
    PLoS One. 2018;13:e0201992.
    >> Share

  476. CHEN J
    The prognostic analysis of different metastatic patterns in advanced liver cancer patients: A population based analysis.
    PLoS One. 2018;13:e0200909.
    >> Share

  477. KIM SE, Park JW, Kim MJ, Jang B, et al
    Accumulation of citrullinated glial fibrillary acidic protein in a mouse model of bile duct ligation-induced hepatic fibrosis.
    PLoS One. 2018;13:e0201744.
    >> Share

  478. ZHENG J, Sadot E, Vigidal JA, Klimstra DS, et al
    Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing.
    PLoS One. 2018;13:e0200776.
    >> Share

  479. VANGOITSENHOVEN R, van der Ende M, Corbeels K, Monteiro Carvalho Mori Cunha JP, et al
    At similar weight loss, dietary composition determines the degree of glycemic improvement in diet-induced obese C57BL/6 mice.
    PLoS One. 2018;13:e0200779.
    >> Share

  480. FINKELMEIER F, Canli O, Peiffer KH, Walter D, et al
    Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis.
    PLoS One. 2018;13:e0200855.
    >> Share

  481. PIASECKI P, Narloch J, Brzozowski K, Ziecina P, et al
    The Predictive Value of SPECT/CT imaging in colorectal liver metastases response after 90Y-radioembolization.
    PLoS One. 2018;13:e0200488.
    >> Share

  482. XU W, Rao Q, An Y, Li M, et al
    Identification of biomarkers for Barcelona Clinic Liver Cancer staging and overall survival of patients with hepatocellular carcinoma.
    PLoS One. 2018;13:e0202763.
    >> Share

  483. GUMMESSON A, Stromberg U, Schmidt C, Kullberg J, et al
    Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: A cross-sectional, population-based study in middle-aged subjects.
    PLoS One. 2018;13:e0202666.
    >> Share

  484. LAPOINTE-SHAW L, Georgie F, Carlone D, Cerocchi O, et al
    Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation study.
    PLoS One. 2018;13:e0201120.
    >> Share

  485. PELEG N, Sneh Arbib O, Issachar A, Cohen-Naftaly M, et al
    Noninvasive scoring systems predict hepatic and extra-hepatic cancers in patients with nonalcoholic fatty liver disease.
    PLoS One. 2018;13:e0202393.
    >> Share

  486. ALISI A, Pampanini V, De Stefanis C, Panera N, et al
    Expression of insulin-like growth factor I and its receptor in the liver of children with biopsy-proven NAFLD.
    PLoS One. 2018;13:e0201566.
    >> Share

  487. WANG Y, Ma L, Yuan Z, Zheng J, et al
    Percutaneous thermal ablation combined with TACE versus TACE monotherapy in the treatment for liver cancer with hepatic vein tumor thrombus: A retrospective study.
    PLoS One. 2018;13:e0201525.
    >> Share

  488. CHOI YJ, Lee DH, Han KD, Yoon H, et al
    Is nonalcoholic fatty liver disease associated with the development of prostate cancer? A nationwide study with 10,516,985 Korean men.
    PLoS One. 2018;13:e0201308.
    >> Share

  489. FABRELLAS N, Hernandez R, Graupera I, Sola E, et al
    Prevalence of hepatic steatosis as assessed by controlled attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population-based study.
    PLoS One. 2018;13:e0200656.
    >> Share

  490. MEHTA AS, Lau DT, Wang M, Islam A, et al
    Application of the Doylestown algorithm for the early detection of hepatocellular carcinoma.
    PLoS One. 2018;13:e0203149.
    >> Share

  491. KRUK B, Liebe R, Milkiewicz M, Wunsch E, et al
    PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC.
    PLoS One. 2018;13:e0202942.
    >> Share

  492. MORI S, Arima N, Ito M, Fujiyama S, et al
    Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment.
    PLoS One. 2018;13:e0203084.
    >> Share

  493. ABDELHAFEZ OH, Fawzy MA, Fahim JR, Desoukey SY, et al
    Hepatoprotective potential of Malvaviscus arboreus against carbon tetrachloride-induced liver injury in rats.
    PLoS One. 2018;13:e0202362.
    >> Share

  494. PEISELER M, Reiners D, Pinnschmidt HO, Sebode M, et al
    Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis.
    PLoS One. 2018;13:e0202686.
    >> Share

  495. KANG SJ, Kim HJ, Kim D, Ahmed A, et al
    Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United States.
    PLoS One. 2018;13:e0202325.
    >> Share

  496. HARRISON SA, Dennis A, Fiore MM, Kelly MD, et al
    Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial.
    PLoS One. 2018;13:e0203054.
    >> Share

  497. KIMER N, Gudmann NS, Pedersen JS, Moller S, et al
    No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial.
    PLoS One. 2018;13:e0203200.
    >> Share

  498. FRANSEN PETTERSSON N, Deronic A, Nilsson J, Hannibal TD, et al
    The immunomodulatory quinoline-3-carboxamide paquinimod reverses established fibrosis in a novel mouse model for liver fibrosis.
    PLoS One. 2018;13:e0203228.
    >> Share

  499. WEGERMANN K, Henao R, Diehl AM, Murphy SK, et al
    Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study.
    PLoS One. 2018;13:e0204308.
    >> Share

  500. ALKHOURI N, Johnson C, Adams L, Kitajima S, et al
    Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis.
    PLoS One. 2018;13:e0202226.
    >> Share

  501. WANG Z, Wang J, Wang P
    The prognostic value of prognostic nutritional index in hepatocellular carcinoma patients: A meta-analysis of observational studies.
    PLoS One. 2018;13:e0202987.
    >> Share

  502. DE BARI B, Breuneval T, Zeverino M, Godin S, et al
    Hepatobiliary scintigraphy allows the evaluation of short-term functional toxicity of liver stereotactic body radiotherapy: Results of a pilot study.
    PLoS One. 2018;13:e0204013.
    >> Share

  503. MIRZADEH A, Yoosefy A, Kazemirad E, Barati Z, et al
    Evaluation of a set of refolded recombinant antigens for serodiagnosis of human fascioliasis.
    PLoS One. 2018;13:e0203490.
    >> Share

  504. WARNER DR, Liu H, Ghosh Dastidar S, Warner JB, et al
    Ethanol and unsaturated dietary fat induce unique patterns of hepatic omega-6 and omega-3 PUFA oxylipins in a mouse model of alcoholic liver disease.
    PLoS One. 2018;13:e0204119.
    >> Share

  505. DILLARD KJ, Hytonen MK, Fischer D, Tanhuanpaa K, et al
    A splice site variant in INPP5E causes diffuse cystic renal dysplasia and hepatic fibrosis in dogs.
    PLoS One. 2018;13:e0204073.
    >> Share

  506. CHOI YR, Chung JW, Yu MH, Lee M, et al
    Diagnostic accuracy of contrast-enhanced dynamic CT for small hypervascular hepatocellular carcinoma and assessment of dynamic enhancement patterns: Results of two-year follow-up using cone-beam CT hepatic arteriography.
    PLoS One. 2018;13:e0203940.
    >> Share

  507. THISTLE JE, Yang B, Petrick JL, Fan JH, et al
    Association of tooth loss with liver cancer incidence and chronic liver disease mortality in a rural Chinese population.
    PLoS One. 2018;13:e0203926.
    >> Share

  508. ROMUALDO GR, Prata GB, da Silva TC, Fernandes AAH, et al
    Fibrosis-associated hepatocarcinogenesis revisited: Establishing standard medium-term chemically-induced male and female models.
    PLoS One. 2018;13:e0203879.
    >> Share

  509. LEE CH, Hung SP, Hong JH, Chang JT, et al
    How small is TOO small? New liver constraint is needed- Proton therapy of hepatocellular carcinoma patients with small normal liver.
    PLoS One. 2018;13:e0203854.
    >> Share

  510. MCCOWAN C, Crameri S, Kocak A, Shan S, et al
    A novel group A rotavirus associated with acute illness and hepatic necrosis in pigeons (Columba livia), in Australia.
    PLoS One. 2018;13:e0203853.
    >> Share

  511. SU L, Chang L, Sun Q, Hu L, et al
    Effects of low-dose energy spectrum scanning combined with adaptive statistical iterative reconstruction on the quality of imaging in Budd-Chiari syndrome.
    PLoS One. 2018;13:e0204797.
    >> Share

  512. TORAIH EA, Alghamdi SA, El-Wazir A, Hosny MM, et al
    Dual biomarkers long non-coding RNA GAS5 and microRNA-34a co-expression signature in common solid tumors.
    PLoS One. 2018;13:e0198231.
    >> Share

  513. GHOBRIAL C, Mogahed EA, El-Karaksy H
    Routine analysis of ascitic fluid for evidence of infection in children with chronic liver disease: Is it mandatory?
    PLoS One. 2018;13:e0203808.
    >> Share

  514. POLINENI D, Piccorelli AV, Hannah WB, Dalrymple SN, et al
    Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population.
    PLoS One. 2018;13:e0205257.
    >> Share

  515. FERRARA-ROMEO I, Martinez P, Blasco MA
    Mice lacking RAP1 show early onset and higher rates of DEN-induced hepatocellular carcinomas in female mice.
    PLoS One. 2018;13:e0204909.
    >> Share

  516. ALMEER RS, El-Khadragy MF, Abdelhabib S, Abdel Moneim AE, et al
    Ziziphus spina-christi leaf extract ameliorates schistosomiasis liver granuloma, fibrosis, and oxidative stress through downregulation of fibrinogenic signaling in mice.
    PLoS One. 2018;13:e0204923.
    >> Share

  517. IOANNOU GN, Green P, Lowy E, Mun EJ, et al
    Differences in hepatocellular carcinoma risk, predictors and trends over time according to etiology of cirrhosis.
    PLoS One. 2018;13:e0204412.
    >> Share

  518. TSAI YW, Tzeng IS, Chen YC, Hsieh TH, et al
    Survival prediction among patients with non-cancer-related end-stage liver disease.
    PLoS One. 2018;13:e0202692.
    >> Share

  519. OKABE H, Yoshizumi T, Yamashita YI, Imai K, et al
    Histological architectural classification determines recurrence pattern and prognosis after curative hepatectomy in patients with hepatocellular carcinoma.
    PLoS One. 2018;13:e0203856.
    >> Share

  520. PETTINELLI P, Arendt BM, Teterina A, McGilvray I, et al
    Altered hepatic genes related to retinol metabolism and plasma retinol in patients with non-alcoholic fatty liver disease.
    PLoS One. 2018;13:e0205747.
    >> Share

  521. LEE SH, Park M, Park KM, Gwag HB, et al
    Corrected QT interval on the electrocardiogram after liver transplantation: Surrogate marker of poor clinical outcomes?
    PLoS One. 2018;13:e0206463.
    >> Share

  522. BHAGAT HA, Compton SA, Musso DL, Laudeman CP, et al
    N-substituted phenylbenzamides of the niclosamide chemotype attenuate obesity related changes in high fat diet fed mice.
    PLoS One. 2018;13:e0204605.
    >> Share

  523. FAROUK S, Sabet S, Abu Zahra FA, El-Ghor AA, et al
    Bone marrow derived-mesenchymal stem cells downregulate IL17A dependent IL6/STAT3 signaling pathway in CCl4-induced rat liver fibrosis.
    PLoS One. 2018;13:e0206130.
    >> Share

  524. SILVA VIEIRA M, Arthurs CJ, Hussain T, Razavi R, et al
    Patient-specific modeling of right coronary circulation vulnerability post-liver transplant in Alagille's syndrome.
    PLoS One. 2018;13:e0205829.
    >> Share

  525. HANDGRAAF HJM, Sibinga Mulder BG, Shahbazi Feshtali S, Boogerd LSF, et al
    Staging laparoscopy with ultrasound and near-infrared fluorescence imaging to detect occult metastases of pancreatic and periampullary cancer.
    PLoS One. 2018;13:e0205960.
    >> Share

  526. JUN BG, Kim SG, Kim YD, Cheon GJ, et al
    Combined therapy of transarterial chemoembolization and stereotactic body radiation therapy versus transarterial chemoembolization for </=5cm hepatocellular carcinoma: Propensity score matching analysis.
    PLoS One. 2018;13:e0206381.
    >> Share

  527. SUH JK, Lee J, Lee JH, Shin S, et al
    Risk factors for developing liver cancer in people with and without liver disease.
    PLoS One. 2018;13:e0206374.
    >> Share

  528. MOSTAFAEI F, Tai A, Omari E, Song Y, et al
    Variations of MRI-assessed peristaltic motions during radiation therapy.
    PLoS One. 2018;13:e0205917.
    >> Share

  529. SUWARTO S, Diahtantri RA, Hidayat MJ, Widjaya B, et al
    Nonalcoholic fatty liver disease is associated with increased hemoconcentration, thrombocytopenia, and longer hospital stay in dengue-infected patients with plasma leakage.
    PLoS One. 2018;13:e0205965.
    >> Share

  530. CHIANG HC, Chien YC, Lin PY, Lee HL, et al
    Assessing men with erectile dysfunction before and after living donor liver transplantation in real-world practice: Integrating laboratories into clinical settings.
    PLoS One. 2018;13:e0206438.
    >> Share

  531. KIM EJ, Chung DH, Kim YJ, Kim YS, et al
    Endobiliary radiofrequency ablation for distal extrahepatic cholangiocarcinoma: A clinicopathological study.
    PLoS One. 2018;13:e0206694.
    >> Share

  532. ADAMS LC, Lubbe F, Bressem K, Wagner M, et al
    Non-alcoholic fatty liver disease in underweight patients with inflammatory bowel disease: A case-control study.
    PLoS One. 2018;13:e0206450.
    >> Share

  533. XIONG Y, Zhang Q, Ye J, Pan S, et al
    Associations between three XRCC1 polymorphisms and hepatocellular carcinoma risk: A meta-analysis of case-control studies.
    PLoS One. 2018;13:e0206853.
    >> Share

  534. CHANG E, Kim DH, Yang H, Lee DH, et al
    CB1 receptor blockade ameliorates hepatic fat infiltration and inflammation and increases Nrf2-AMPK pathway in a rat model of severely uncontrolled diabetes.
    PLoS One. 2018;13:e0206152.
    >> Share

  535. BONKOVSKY HL, Barnhart HX, Foureau DM, Steuerwald N, et al
    Cytokine profiles in acute liver injury-Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group.
    PLoS One. 2018;13:e0206389.
    >> Share

  536. LIEN HC, Jeng YM, Jhuang YL, Yuan RH, et al
    Increased Trimethylation of histone H3K36 associates with biliary differentiation and predicts poor prognosis in resectable hepatocellular carcinoma.
    PLoS One. 2018;13:e0206261.
    >> Share

  537. VAN DER WAALS LM, Borel Rinkes IHM, Kranenburg O
    ALDH1A1 expression is associated with poor differentiation, 'right-sidedness' and poor survival in human colorectal cancer.
    PLoS One. 2018;13:e0205536.
    >> Share

  538. DAHER S, Lev Cohen N, Massarwa M, Mahamid M, et al
    Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.
    PLoS One. 2018;13:e0207479.
    >> Share

  539. DEGROAT AR, Fleming CK, Dunlay SM, Hagood KL, et al
    The sex specific effect of alcohol consumption on circulating levels of CTRP3.
    PLoS One. 2018;13:e0207011.
    >> Share

  540. MEHTA R, Shaw G, Masschelin P, Felix S, et al
    Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH).
    PLoS One. 2018;13:e0199294.
    >> Share

  541. NAVARRO-ALVAREZ N, Machaidze Z, Schuetz C, Zhu A, et al
    Xenogeneic Heterotopic Auxiliary Liver transplantation (XHALT) promotes native liver regeneration in a Post-Hepatectomy Liver failure model.
    PLoS One. 2018;13:e0207272.
    >> Share

  542. KUBESCH A, Quenstedt L, Saleh M, Ruschenbaum S, et al
    Vitamin D deficiency is associated with hepatic decompensation and inflammation in patients with liver cirrhosis: A prospective cohort study.
    PLoS One. 2018;13:e0207162.
    >> Share

  543. HSIEH YC, Lee KC, Wang YW, Yang YY, et al
    Correlation and prognostic accuracy between noninvasive liver fibrosismarkers and portal pressure in cirrhosis: Role of ALBI score.
    PLoS One. 2018;13:e0208903.
    >> Share

  544. SCHUBERT M, Hackl H, Gassner FJ, Greil R, et al
    Investigating epigenetic effects of activation-induced deaminase in chronic lymphocytic leukemia.
    PLoS One. 2018;13:e0208753.
    >> Share

    January 2017
  545. CARVALHO AC, Leal F, Sasse AD
    Cost-effectiveness of cetuximab and panitumumab for chemotherapy-refractory metastatic colorectal cancer.
    PLoS One. 2017;12:e0175409.
    >> Share

  546. GERTH HU, Pohlen M, Tholking G, Pavenstadt H, et al
    Molecular adsorbent recirculating system (MARS) in acute liver injury and graft dysfunction: Results from a case-control study.
    PLoS One. 2017;12:e0175529.
    >> Share

  547. YAO L, Chen W, Song K, Han C, et al
    15-hydroxyprostaglandin dehydrogenase (15-PGDH) prevents lipopolysaccharide (LPS)-induced acute liver injury.
    PLoS One. 2017;12:e0176106.
    >> Share

  548. LYTLE KA, Wong CP, Jump DB
    Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.
    PLoS One. 2017;12:e0173376.
    >> Share

  549. HE J, Yi B, Chen Y, Huang Q, et al
    The ET-1-mediated carbonylation and degradation of ANXA1 induce inflammatory phenotype and proliferation of pulmonary artery smooth muscle cells in HPS.
    PLoS One. 2017;12:e0175443.
    >> Share

  550. ALVA A, Cangalaya C, Quiliano M, Krebs C, et al
    Mathematical algorithm for the automatic recognition of intestinal parasites.
    PLoS One. 2017;12:e0175646.
    >> Share

  551. PEREZ P, Rodriguez-Peralvarez M, Guerrero L, Gonzalez V, et al
    Incidental hepatocellular carcinoma after liver transplantation: Prevalence, histopathological features and prognostic impact.
    PLoS One. 2017;12:e0175010.
    >> Share

  552. IBUSUKI R, Uto H, Oda K, Ohshige A, et al
    Human neutrophil peptide-1 promotes alcohol-induced hepatic fibrosis and hepatocyte apoptosis.
    PLoS One. 2017;12:e0174913.
    >> Share

  553. PEREYRA D, Offensperger F, Klinglmueller F, Haegele S, et al
    Early prediction of postoperative liver dysfunction and clinical outcome using antithrombin III-activity.
    PLoS One. 2017;12:e0175359.
    >> Share

  554. KANG YM, Jung CH, Cho YK, Lee SE, et al
    Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population.
    PLoS One. 2017;12:e0175762.
    >> Share

  555. YOON K, Jeong WK, Kim Y, Kim MY, et al
    2-dimensional shear wave elastography: Interobserver agreement and factors related to interobserver discrepancy.
    PLoS One. 2017;12:e0175747.
    >> Share

  556. ROTH JA, Widmer AF, Tschudin-Sutter S, Dangel M, et al
    The Model for End-stage Liver Disease (MELD) as a predictor of short-term mortality in Staphylococcus aureus bloodstream infection: A single-centre observational study.
    PLoS One. 2017;12:e0175669.
    >> Share

  557. WANKHADE UD, Zhong Y, Kang P, Alfaro M, et al
    Enhanced offspring predisposition to steatohepatitis with maternal high-fat diet is associated with epigenetic and microbiome alterations.
    PLoS One. 2017;12:e0175675.
    >> Share

  558. MCPHERSON S, Wilkinson N, Tiniakos D, Wilkinson J, et al
    A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis.
    PLoS One. 2017;12:e0175717.
    >> Share

  559. YANG SC, Hsu CN, Liang CM, Tai WC, et al
    Risk of Rebleeding and Mortality in Cirrhotic Patients with Peptic Ulcer Bleeding: A 12-Year Nationwide Cohort Study.
    PLoS One. 2017;12:e0168918.
    >> Share

  560. MULDER P, van den Hoek AM, Kleemann R
    The CCR2 Inhibitor Propagermanium Attenuates Diet-Induced Insulin Resistance, Adipose Tissue Inflammation and Non-Alcoholic Steatohepatitis.
    PLoS One. 2017;12:e0169740.
    >> Share

  561. WANG HL, Zhang H, Wu SL, Liao GC, et al
    Red blood cell count has an independent contribution to the prediction of ultrasonography-diagnosed fatty liver disease.
    PLoS One. 2017;12:e0172027.
    >> Share

  562. GRZELAK CA, Sigglekow ND, Tirnitz-Parker JE, Hamson EJ, et al
    Widespread GLI expression but limited canonical hedgehog signaling restricted to the ductular reaction in human chronic liver disease.
    PLoS One. 2017;12:e0171480.
    >> Share

  563. GIMENEZ-GARZO C, Garces JJ, Urios A, Mangas-Losada A, et al
    The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients.
    PLoS One. 2017;12:e0171211.
    >> Share

  564. TRAYKOVA D, Schneider B, Chojkier M, Buck M, et al
    Blood Microbiome Quantity and the Hyperdynamic Circulation in Decompensated Cirrhotic Patients.
    PLoS One. 2017;12:e0169310.
    >> Share

  565. HU W, Shao X, Guo D, Hao H, et al
    Relationship of Serum Betatrophin with Nonalcoholic Fatty Liver in a Chinese Population.
    PLoS One. 2017;12:e0170758.
    >> Share

  566. CROOME KP, Lee DD, Harnois D, Taner CB, et al
    Effects of the Share 35 Rule on Waitlist and Liver Transplantation Outcomes for Patients with Hepatocellular Carcinoma.
    PLoS One. 2017;12:e0170673.
    >> Share

  567. ZHAO J, Zhai F, Cheng J, He Q, et al
    Evaluating the Significance of Viscoelasticity in Diagnosing Early-Stage Liver Fibrosis with Transient Elastography.
    PLoS One. 2017;12:e0170073.
    >> Share

  568. XU X, Su L, Gao Y, Ding Y, et al
    The Prevalence of Nonalcoholic Fatty Liver Disease and Related Metabolic Comorbidities Was Associated with Age at Onset of Moderate to Severe Plaque Psoriasis: A Cross-Sectional Study.
    PLoS One. 2017;12:e0169952.
    >> Share

  569. WAKAMATSU T, Ogasawara S, Chiba T, Yokoyama M, et al
    Impact of Radiofrequency Ablation-Induced Glisson's Capsule-Associated Complications in Patients with Hepatocellular Carcinoma.
    PLoS One. 2017;12:e0170153.
    >> Share

  570. RISHI P, Arora S, Kaur UJ, Chopra K, et al
    Better Management of Alcohol Liver Disease Using a 'Microstructured Synbox' System Comprising L. plantarum and EGCG.
    PLoS One. 2017;12:e0168459.
    >> Share

  571. YOUNS M, Abdel Halim Hegazy W
    The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways.
    PLoS One. 2017;12:e0169335.
    >> Share

  572. KARAJAMAKI AJ, Kettunen O, Lepojarvi S, Koivurova OP, et al
    Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population.
    PLoS One. 2017;12:e0173855.
    >> Share

  573. CANNITO S, Morello E, Bocca C, Foglia B, et al
    Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis.
    PLoS One. 2017;12:e0172575.
    >> Share

  574. JIN F, Wan C, Li W, Yao L, et al
    Formononetin protects against acetaminophen-induced hepatotoxicity through enhanced NRF2 activity.
    PLoS One. 2017;12:e0170900.
    >> Share

  575. SOTHMANN T, Gauer T, Werner R
    4D dose simulation in volumetric arc therapy: Accuracy and affecting parameters.
    PLoS One. 2017;12:e0172810.
    >> Share

  576. HOLLENBACH M, Thonig A, Pohl S, Ripoll C, et al
    Expression of glyoxalase-I is reduced in cirrhotic livers: A possible mechanism in the development of cirrhosis.
    PLoS One. 2017;12:e0171260.
    >> Share

  577. SHEU MJ, Hsieh MJ, Chou YE, Wang PH, et al
    Effects of ADAMTS14 genetic polymorphism and cigarette smoking on the clinicopathologic development of hepatocellular carcinoma.
    PLoS One. 2017;12:e0172506.
    >> Share

  578. BORGATTI A, Winter AL, Stuebner K, Scott R, et al
    Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma - A pilot study.
    PLoS One. 2017;12:e0172651.
    >> Share

  579. LI Q, Wang Y, Ma T, Lv Y, et al
    Clinical outcomes of patients with and without diabetes mellitus after hepatectomy: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0171129.
    >> Share

  580. ZHANG BB, Yan C, Fang F, Du Y, et al
    Increased hepatic Th2 and Treg subsets are associated with biliary fibrosis in different strains of mice caused by Clonorchis sinensis.
    PLoS One. 2017;12:e0171005.
    >> Share

  581. WERNLY B, Lichtenauer M, Franz M, Kabisch B, et al
    Model for End-stage Liver Disease excluding INR (MELD-XI) score in critically ill patients: Easily available and of prognostic relevance.
    PLoS One. 2017;12:e0170987.
    >> Share

  582. SALDANA RS, Schrem H, Barthold M, Kaltenborn A, et al
    Prognostic Abilities and Quality Assessment of Models for the Prediction of 90-Day Mortality in Liver Transplant Waiting List Patients.
    PLoS One. 2017;12:e0170499.
    >> Share

  583. YOO JE, Kim YJ, Rhee H, Kim H, et al
    Progressive Enrichment of Stemness Features and Tumor Stromal Alterations in Multistep Hepatocarcinogenesis.
    PLoS One. 2017;12:e0170465.
    >> Share

  584. LEE DH, Lee JH, Jung YJ, Gim J, et al
    Validation of a Modified Child-Turcotte-Pugh Classification System Utilizing Insulin-Like Growth Factor-1 for Patients with Hepatocellular Carcinoma in an HBV Endemic Area.
    PLoS One. 2017;12:e0170394.
    >> Share

  585. GAO W, Zhao J, Gao Z, Li H, et al
    Synergistic Interaction of Light Alcohol Administration in the Presence of Mild Iron Overload in a Mouse Model of Liver Injury: Involvement of Triosephosphate Isomerase Nitration and Inactivation.
    PLoS One. 2017;12:e0170350.
    >> Share

  586. LEE LH, Hwang JI, Cheng YC, Wu CY, et al
    Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma.
    PLoS One. 2017;12:e0169655.
    >> Share

  587. LU M, Zessin AS, Glover W, Hsu DS, et al
    Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis.
    PLoS One. 2017;12:e0169439.
    >> Share

  588. LE MH, Devaki P, Ha NB, Jun DW, et al
    Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States.
    PLoS One. 2017;12:e0173499.
    >> Share

  589. MO HY, Liao YY, You XM, Cucchetti A, et al
    Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy.
    PLoS One. 2017;12:e0174222.
    >> Share

  590. MA S, Yang J, Song C, Ge Z, et al
    Expression quantitative trait loci for PAX8 contributes to the prognosis of hepatocellular carcinoma.
    PLoS One. 2017;12:e0173700.
    >> Share

  591. TROUVE P, Genin E, Ferec C
    In silico search for modifier genes associated with pancreatic and liver disease in Cystic Fibrosis.
    PLoS One. 2017;12:e0173822.
    >> Share

  592. ABO-HADED HM, Elkablawy MA, Al-Johani Z, Al-Ahmadi O, et al
    Hepatoprotective effect of sitagliptin against methotrexate induced liver toxicity.
    PLoS One. 2017;12:e0174295.
    >> Share

  593. XIE Z, Wang J, Liu M, Chen D, et al
    CC-223 blocks mTORC1/C2 activation and inhibits human hepatocellular carcinoma cells in vitro and in vivo.
    PLoS One. 2017;12:e0173252.
    >> Share

  594. BECKER S, Kinny-Koster B, Bartels M, Scholz M, et al
    Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosis.
    PLoS One. 2017;12:e0174424.
    >> Share

  595. SU YW, Liu PH, Hsu CY, Lee YH, et al
    Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective.
    PLoS One. 2017;12:e0174333.
    >> Share

  596. HOLMILA R, Sklias A, Muller DC, Degli Esposti D, et al
    Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinoma.
    PLoS One. 2017;12:e0174265.
    >> Share

  597. LOWDON RF, Wang T
    Epigenomic annotation of noncoding mutations identifies mutated pathways in primary liver cancer.
    PLoS One. 2017;12:e0174032.
    >> Share

  598. WIEGERING A, Riegel J, Wagner J, Kunzmann V, et al
    The impact of pulmonary metastasectomy in patients with previously resected colorectal cancer liver metastases.
    PLoS One. 2017;12:e0173933.
    >> Share

  599. GUTIERREZ-DE-JUAN V, Lopez de Davalillo S, Fernandez-Ramos D, Barbier-Torres L, et al
    A morphological method for ammonia detection in liver.
    PLoS One. 2017;12:e0173914.
    >> Share

  600. INZAUGARAT ME, De Matteo E, Baz P, Lucero D, et al
    New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans.
    PLoS One. 2017;12:e0172900.
    >> Share

  601. KATHER JN, Zollner FG, Schad LR, Melchers SM, et al
    Identification of a characteristic vascular belt zone in human colorectal cancer.
    PLoS One. 2017;12:e0171378.
    >> Share

  602. LEE J, Yoon K, Ryu S, Chang Y, et al
    High-normal levels of hs-CRP predict the development of non-alcoholic fatty liver in healthy men.
    PLoS One. 2017;12:e0172666.
    >> Share

  603. WU PY, Cheng CY, Liu CE, Lee YC, et al
    Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naive HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan.
    PLoS One. 2017;12:e0171596.
    >> Share

  604. PRAJAPATI HJ, Kim HS
    Treatment algorithm based on the multivariate survival analyses in patients with advanced hepatocellular carcinoma treated with trans-arterial chemoembolization.
    PLoS One. 2017;12:e0170750.
    >> Share

  605. TAI CS, Lin YR, Teng TH, Lin PY, et al
    Haptoglobin expression correlates with tumor differentiation and five-year overall survival rate in hepatocellular carcinoma.
    PLoS One. 2017;12:e0171269.
    >> Share

  606. VAN DEN BERG EH, Amini M, Schreuder TC, Dullaart RP, et al
    Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.
    PLoS One. 2017;12:e0171502.
    >> Share

  607. LACOSTE B, Raymond VA, Cassim S, Lapierre P, et al
    Highly tumorigenic hepatocellular carcinoma cell line with cancer stem cell-like properties.
    PLoS One. 2017;12:e0171215.
    >> Share

  608. KAJI K, Mizukoshi E, Yamashita T, Arai K, et al
    Cellular Immune Responses for Squamous Cell Carcinoma Antigen Recognized by T Cells 3 in Patients with Hepatocellular Carcinoma.
    PLoS One. 2017;12:e0170291.
    >> Share

  609. CHENG SB, Liu HT, Chen SY, Lin PT, et al
    Changes of Oxidative Stress, Glutathione, and Its Dependent Antioxidant Enzyme Activities in Patients with Hepatocellular Carcinoma before and after Tumor Resection.
    PLoS One. 2017;12:e0170016.
    >> Share

  610. LI C, Ni J, Liu YX, Wang H, et al
    Response of MiRNA-22-3p and MiRNA-149-5p to Folate Deficiency and the Differential Regulation of MTHFR Expression in Normal and Cancerous Human Hepatocytes.
    PLoS One. 2017;12:e0168049.
    >> Share

  611. YOO HJ, Hwang SY, Choi JH, Lee HJ, et al
    Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis.
    PLoS One. 2017;12:e0174717.
    >> Share

  612. TAKAHASHI A, Kono S, Wada A, Oshima S, et al
    Reduced brain activity in female patients with non-alcoholic fatty liver disease as measured by near-infrared spectroscopy.
    PLoS One. 2017;12:e0174169.
    >> Share

  613. KOMIYAMA Y, Kurosaki M, Nakanishi H, Takahashi Y, et al
    Prediction of diuretic response to tolvaptan by a simple, readily available spot urine Na/K ratio.
    PLoS One. 2017;12:e0174649.
    >> Share

  614. LEE M, Jo A, Lee S, Kim JB, et al
    3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells.
    PLoS One. 2017;12:e0174271.
    >> Share

  615. GAO B, Zhang X, Huang Y, Yang Z, et al
    Coding and non-coding gene regulatory networks underlie the immune response in liver cirrhosis.
    PLoS One. 2017;12:e0174142.
    >> Share

  616. JIN X, Liu J, Chen YP, Xiang Z, et al
    Effect of miR-146 targeted HDMCP up-regulation in the pathogenesis of nonalcoholic steatohepatitis.
    PLoS One. 2017;12:e0174218.
    >> Share

  617. LI Y, Dong Y, Huang Z, Kuang Q, et al
    Computational identifying and characterizing circular RNAs and their associated genes in hepatocellular carcinoma.
    PLoS One. 2017;12:e0174436.
    >> Share

  618. STRATIGOPOULOU P, Paul A, Hoyer DP, Kykalos S, et al
    High MELD score and extended operating time predict prolonged initial ICU stay after liver transplantation and influence the outcome.
    PLoS One. 2017;12:e0174173.
    >> Share

  619. LEE JS, Yoo JE, Kim H, Rhee H, et al
    Tumor stroma with senescence-associated secretory phenotype in steatohepatitic hepatocellular carcinoma.
    PLoS One. 2017;12:e0171922.
    >> Share

  620. WANG Y, Stewart E, Desjardins L, Hadway J, et al
    Assessment of intratumor hypoxia by integrated 18F-FDG PET / perfusion CT in a liver tumor model.
    PLoS One. 2017;12:e0173016.
    >> Share

  621. DIJKSTRA H, Wolff D, van Melle JP, Bartelds B, et al
    Diminished liver microperfusion in Fontan patients: A biexponential DWI study.
    PLoS One. 2017;12:e0173149.
    >> Share

  622. LEDE V, Meusel A, Garten A, Popkova Y, et al
    Altered hepatic lipid metabolism in mice lacking both the melanocortin type 4 receptor and low density lipoprotein receptor.
    PLoS One. 2017;12:e0172000.
    >> Share

  623. WU L, Pang Y, Qin G, Xi G, et al
    Farnesylthiosalicylic acid sensitizes hepatocarcinoma cells to artemisinin derivatives.
    PLoS One. 2017;12:e0171840.
    >> Share

  624. ZHU Z, Tran H, Mathahs MM, Moninger TO, et al
    HCV Induces Telomerase Reverse Transcriptase, Increases Its Catalytic Activity, and Promotes Caspase Degradation in Infected Human Hepatocytes.
    PLoS One. 2017;12:e0166853.
    >> Share

  625. LEE SM, Lee JM, Kang HJ, Yang HK, et al
    Liver fibrosis staging with a new 2D-shear wave elastography using comb-push technique: Applicability, reproducibility, and diagnostic performance.
    PLoS One. 2017;12:e0177264.
    >> Share

  626. YANG C, Yang S, Xu W, Zhang J, et al
    Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: A retrospective cohort study.
    PLoS One. 2017;12:e0177249.
    >> Share

  627. HUANG JF, Yeh ML, Huang CF, Huang CI, et al
    Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients.
    PLoS One. 2017;12:e0174394.
    >> Share

  628. ZHANG S, Xiao Q, Shi Z, Yu G, et al
    Caspase polymorphisms and prognosis of hepatocellular carcinoma.
    PLoS One. 2017;12:e0176802.
    >> Share

  629. RUEDA-ZARATE HA, Imaz-Rosshandler I, Cardenas-Ovando RA, Castillo-Fernandez JE, et al
    A computational toxicogenomics approach identifies a list of highly hepatotoxic compounds from a large microarray database.
    PLoS One. 2017;12:e0176284.
    >> Share

  630. NAOUR S, Espinoza BM, Aedo JE, Zuloaga R, et al
    Transcriptomic analysis of the hepatic response to stress in the red cusk-eel (Genypterus chilensis): Insights into lipid metabolism, oxidative stress and liver steatosis.
    PLoS One. 2017;12:e0176447.
    >> Share

  631. CHANG W, Lee JM, Yoon JH, Lee DH, et al
    No-touch radiofrequency ablation using multiple electrodes: An in vivo comparison study of switching monopolar versus switching bipolar modes in porcine livers.
    PLoS One. 2017;12:e0176350.
    >> Share

  632. ROKUSZ A, Veres D, Szucs A, Bugyik E, et al
    Ductular reaction correlates with fibrogenesis but does not contribute to liver regeneration in experimental fibrosis models.
    PLoS One. 2017;12:e0176518.
    >> Share

  633. ADEJUMO AC, Alliu S, Ajayi TO, Adejumo KL, et al
    Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study.
    PLoS One. 2017;12:e0176416.
    >> Share

  634. OLDRINI G, Huertas A, Renard-Oldrini S, Taste-George H, et al
    Tumor response assessment by MRI following stereotactic body radiation therapy for hepatocellular carcinoma.
    PLoS One. 2017;12:e0176118.
    >> Share

  635. ESTIU MC, Frailuna MA, Otero C, Dericco M, et al
    Relationship between early onset severe intrahepatic cholestasis of pregnancy and higher risk of meconium-stained fluid.
    PLoS One. 2017;12:e0176504.
    >> Share

  636. YEN YH, Chen JB, Cheng BC, Chen JF, et al
    Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study.
    PLoS One. 2017;12:e0176027.
    >> Share

  637. LEE HL, Cheng HL, Liu YF, Chou MC, et al
    Functional genetic variant of WW domain-containing oxidoreductase (WWOX) gene is associated with hepatocellular carcinoma risk.
    PLoS One. 2017;12:e0176141.
    >> Share

  638. YANG KL, Chang WT, Hong MY, Hung KC, et al
    Prevention of TGF-beta-induced early liver fibrosis by a maleic acid derivative anti-oxidant through suppression of ROS, inflammation and hepatic stellate cells activation.
    PLoS One. 2017;12:e0174008.
    >> Share

  639. LAHTI S, Ludwig JM, Xing M, Sun L, et al
    In vitro biologic efficacy of sunitinib drug-eluting beads on human colorectal and hepatocellular carcinoma-A pilot study.
    PLoS One. 2017;12:e0174539.
    >> Share

  640. CHAN M, Chiang CL, Lee V, Cheung S, et al
    Target localization of 3D versus 4D cone beam computed tomography in lipiodol-guided stereotactic radiotherapy of hepatocellular carcinomas.
    PLoS One. 2017;12:e0174929.
    >> Share

  641. PEYROUX E, Santaella N, Broussolle E, Rigard C, et al
    Social cognition in Wilson's disease: A new phenotype?
    PLoS One. 2017;12:e0173467.
    >> Share

  642. HERRADOR Z, Fernandez-Martinez A, Gomez-Barroso D, Leon I, et al
    Mediterranean spotted fever in Spain, 1997-2014: Epidemiological situation based on hospitalization records.
    PLoS One. 2017;12:e0174745.
    >> Share

  643. HE CB, Lin XJ
    Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
    PLoS One. 2017;12:e0174769.
    >> Share

  644. CHU YW, Lin HM, Wang JJ, Weng SF, et al
    Epidemiology and outcomes of hypoglycemia in patients with advanced diabetic kidney disease on dialysis: A national cohort study.
    PLoS One. 2017;12:e0174601.
    >> Share

  645. WANG YC, Chou CT, Lin CP, Chen YL, et al
    The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images.
    PLoS One. 2017;12:e0174594.
    >> Share

  646. LI Y, Wang J, Tang Y, Han X, et al
    Bidirectional association between nonalcoholic fatty liver disease and type 2 diabetes in Chinese population: Evidence from the Dongfeng-Tongji cohort study.
    PLoS One. 2017;12:e0174291.
    >> Share

  647. KRAWCZYK M, Zimmermann S, Hess G, Holz R, et al
    Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease.
    PLoS One. 2017;12:e0173506.
    >> Share

  648. SONG YN, Dong S, Wei B, Liu P, et al
    Metabolomic mechanisms of gypenoside against liver fibrosis in rats: An integrative analysis of proteomics and metabolomics data.
    PLoS One. 2017;12:e0173598.
    >> Share

  649. VALBUSA F, Bonapace S, Agnoletti D, Scala L, et al
    Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure.
    PLoS One. 2017;12:e0173398.
    >> Share

  650. HAGLUND S, Vikingsson S, Almer S, Soderman J, et al
    Combination treatment with 6-mercaptopurine and allopurinol in HepG2 and HEK293 cells - Effects on gene expression levels and thiopurine metabolism.
    PLoS One. 2017;12:e0173825.
    >> Share

  651. TAKAHARA I, Akazawa Y, Tabuchi M, Matsuda K, et al
    Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice.
    PLoS One. 2017;12:e0170591.
    >> Share

  652. WILMAN HR, Kelly M, Garratt S, Matthews PM, et al
    Characterisation of liver fat in the UK Biobank cohort.
    PLoS One. 2017;12:e0172921.
    >> Share

  653. WEN YF, Yang XZ, Zeng LS, Peng HH, et al
    Prognostic impact of pretherapeutic gamma-glutamyltransferase on patients with nasopharyngeal carcinoma.
    PLoS One. 2017;12:e0172345.
    >> Share

  654. XUE M, Liu Y, Lyu R, Ge N, et al
    Protective effect of aplysin on liver tissue and the gut microbiota in alcohol-fed rats.
    PLoS One. 2017;12:e0178684.
    >> Share

  655. JOLY P, Vignaud H, Di Martino J, Ruiz M, et al
    ERAD defects and the HFE-H63D variant are associated with increased risk of liver damages in Alpha 1-Antitrypsin Deficiency.
    PLoS One. 2017;12:e0179369.
    >> Share

  656. RAO ZZ, Zhang XW, Ding YL, Yang MY, et al
    miR-148a-mediated estrogen-induced cholestasis in intrahepatic cholestasis of pregnancy: Role of PXR/MRP3.
    PLoS One. 2017;12:e0178702.
    >> Share

  657. SIGRUENER A, Wolfrum C, Boettcher A, Kopf T, et al
    Lipidomic and metabolic changes in the P4-type ATPase ATP10D deficient C57BL/6J wild type mice upon rescue of ATP10D function.
    PLoS One. 2017;12:e0178368.
    >> Share

  658. BUECHTER M, Kahraman A, Manka P, Gerken G, et al
    Partial spleen embolization reduces the risk of portal hypertension-induced upper gastrointestinal bleeding in patients not eligible for TIPS implantation.
    PLoS One. 2017;12:e0177401.
    >> Share

  659. PRIETO V, Ludwig JM, Farris AB, Nagaraju GP, et al
    Establishment of human metastatic colorectal cancer model in rabbit liver: A pilot study.
    PLoS One. 2017;12:e0177212.
    >> Share

  660. LAI LL, Chan WK, Sthaneshwar P, Nik Mustapha NR, et al
    Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0174982.
    >> Share

  661. ASTROM E, Stal P, Zenlander R, Edenvik P, et al
    Reverse lectin ELISA for detecting fucosylated forms of alpha1-acid glycoprotein associated with hepatocellular carcinoma.
    PLoS One. 2017;12:e0173897.
    >> Share

  662. HUH JH, Kim JY, Choi E, Kim JS, et al
    The fatty liver index as a predictor of incident chronic kidney disease in a 10-year prospective cohort study.
    PLoS One. 2017;12:e0180951.
    >> Share

  663. LIU W, Li X, Zhou B, Fang S, et al
    Differential induction of apoptosis and autophagy by pyrrolizidine alkaloid clivorine in human hepatoma Huh-7.5 cells and its toxic implication.
    PLoS One. 2017;12:e0179379.
    >> Share

  664. PARK SH, Won HJ, Kim SY, Shin YM, et al
    Efficacy and safety of ultrasound-guided implantation of fiducial markers in the liver for stereotactic body radiation therapy.
    PLoS One. 2017;12:e0179676.
    >> Share

  665. GRANATA V, Fusco R, Catalano O, Avallone A, et al
    Diagnostic accuracy of magnetic resonance, computed tomography and contrast enhanced ultrasound in radiological multimodality assessment of peribiliary liver metastases.
    PLoS One. 2017;12:e0179951.
    >> Share

  666. CHANG CC, Lee WS, Hsieh HG, Chuang CL, et al
    Selective cyclooxygenase inhibition by SC-560 improves hepatopulmonary syndrome in cirrhotic rats.
    PLoS One. 2017;12:e0179809.
    >> Share

  667. PEREIRA ENGDS, Silvares RR, Flores EEI, Rodrigues KL, et al
    Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0179654.
    >> Share

  668. GAO B, Yu T, Xue D, Sun B, et al
    A multidimensional integration analysis reveals potential bridging targets in the process of colorectal cancer liver metastasis.
    PLoS One. 2017;12:e0178760.
    >> Share

  669. DOLD L, Luda C, Schwarze-Zander C, Boesecke C, et al
    Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART).
    PLoS One. 2017;12:e0178685.
    >> Share

  670. NAKADE Y, Sakamoto K, Yamauchi T, Inoue T, et al
    Conophylline inhibits non-alcoholic steatohepatitis in mice.
    PLoS One. 2017;12:e0178436.
    >> Share

  671. CHANG YP, Chen YM, Lai CH, Lin CY, et al
    The impact of de novo liver metastasis on clinical outcome in patients with advanced non-small-cell lung cancer.
    PLoS One. 2017;12:e0178676.
    >> Share

  672. HAN EC, Ryoo SB, Park JW, Yi JW, et al
    Oncologic and surgical outcomes in colorectal cancer patients with liver cirrhosis: A propensity-matched study.
    PLoS One. 2017;12:e0178920.
    >> Share

  673. ANDRIANTSOA M, Hoibian S, Autret A, Gilabert M, et al
    An elevated serum alkaline phosphatase level in hepatic metastases of grade 1 and 2 gastrointestinal neuroendocrine tumors is unusual and of prognostic value.
    PLoS One. 2017;12:e0177971.
    >> Share

  674. LO CH, Yang JF, Liu MY, Jen YM, et al
    Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapy.
    PLoS One. 2017;12:e0177793.
    >> Share

  675. LIN WC, Lin HH, Hung CY, Shih SC, et al
    Clinical endoscopic management and outcome of post-endoscopic sphincterotomy bleeding.
    PLoS One. 2017;12:e0177449.
    >> Share

  676. KAFFARNIK MF, Ahmadi N, Lock JF, Wuensch T, et al
    Correlation between plasma endothelin-1 levels and severity of septic liver failure quantified by maximal liver function capacity (LiMAx test). A prospective study.
    PLoS One. 2017;12:e0178237.
    >> Share

  677. SORENSON EC, Khanin R, Bamboat ZM, Cavnar MJ, et al
    Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation.
    PLoS One. 2017;12:e0176562.
    >> Share

  678. KREMERS RMW, Kleinegris MC, Ninivaggi M, de Laat B, et al
    Decreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosis.
    PLoS One. 2017;12:e0177020.
    >> Share

  679. WANG C, Yang Y, Sun D, Jiang Y, et al
    Prognosis of hepatocellular carcinoma patients with bile duct tumor thrombus after hepatic resection or liver transplantation in Asian populations: A meta-analysis.
    PLoS One. 2017;12:e0176827.
    >> Share

  680. WONG MW, Chen MJ, Chen HL, Kuo YC, et al
    Application of chronic liver failure-sequential organ failure assessment score for the predication of mortality after esophageal variceal hemorrhage post endoscopic ligation.
    PLoS One. 2017;12:e0182529.
    >> Share

  681. LI SC, Lee CH, Hung CL, Wu JC, et al
    Surgical resection of metachronous hepatic metastases from gastric cancer improves long-term survival: A population-based study.
    PLoS One. 2017;12:e0182255.
    >> Share

  682. KIM G, Kim KJ, Rhee Y, Lim SK, et al
    Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0182202.
    >> Share

  683. HUA MC, Su HM, Yao TC, Kuo ML, et al
    Alternation of plasma fatty acids composition and desaturase activities in children with liver steatosis.
    PLoS One. 2017;12:e0182277.
    >> Share

  684. HUNG TH, Liang CM, Hsu CN, Tai WC, et al
    Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in Taiwan.
    PLoS One. 2017;12:e0181858.
    >> Share

  685. LIU P, Xu Y, Tang Y, Du M, et al
    Independent and joint effects of moderate alcohol consumption and smoking on the risks of non-alcoholic fatty liver disease in elderly Chinese men.
    PLoS One. 2017;12:e0181497.
    >> Share

  686. SCHLEGEL V, Treuner-Kaueroff T, Seehofer D, Berg T, et al
    Low PCSK9 levels are correlated with mortality in patients with end-stage liver disease.
    PLoS One. 2017;12:e0181540.
    >> Share

  687. GOEBEL J, Sulke M, Lazik-Palm A, Goebel T, et al
    Factors associated with contralateral liver hypertrophy after unilateral radioembolization for hepatocellular carcinoma.
    PLoS One. 2017;12:e0181488.
    >> Share

  688. KAUFMANN B, Wang B, Zhong S, Laschinger M, et al
    BRG1 promotes hepatocarcinogenesis by regulating proliferation and invasiveness.
    PLoS One. 2017;12:e0180225.
    >> Share

  689. KIRCHNER J, Sawicki LM, Deuschl C, Gruneisen J, et al
    18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
    PLoS One. 2017;12:e0180349.
    >> Share

  690. RISSIN DM, Lopez-Longarela B, Pernagallo S, Ilyine H, et al
    Polymerase-free measurement of microRNA-122 with single base specificity using single molecule arrays: Detection of drug-induced liver injury.
    PLoS One. 2017;12:e0179669.
    >> Share

  691. CAI G, Chen B, Li Z, Wei W, et al
    The different expressed serum proteins in rhCygb treated rat model of liver fibrosis by the optimized two-dimensional gel electrophoresis.
    PLoS One. 2017;12:e0177968.
    >> Share

  692. KAMMOUN HL, Allen TL, Henstridge DC, Kraakman MJ, et al
    Over-expressing the soluble gp130-Fc does not ameliorate methionine and choline deficient diet-induced non alcoholic steatohepatitis in mice.
    PLoS One. 2017;12:e0179099.
    >> Share

  693. MATSUMOTO K, Ichimura M, Tsuneyama K, Moritoki Y, et al
    Fructo-oligosaccharides and intestinal barrier function in a methionine-choline-deficient mouse model of nonalcoholic steatohepatitis.
    PLoS One. 2017;12:e0175406.
    >> Share

  694. KAMIMURA K, Yokoo T, Kamimura H, Sakamaki A, et al
    Long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients: Patient-reported outcome based analyses.
    PLoS One. 2017;12:e0178991.
    >> Share

  695. KIM HM, Kim YM, Huh JH, Lee ES, et al
    alpha-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2.
    PLoS One. 2017;12:e0179204.
    >> Share

  696. KLOTTER V, Gunchick C, Siemers E, Rath T, et al
    Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: Results from a prospective longitudinal cohort study.
    PLoS One. 2017;12:e0178784.
    >> Share

  697. SOGABE M, Okahisa T, Nakasono M, Fukuno H, et al
    The differing influence of several factors on the development of fatty liver with elevation of liver enzymes between genders with metabolic syndrome: A cross-sectional study.
    PLoS One. 2017;12:e0177925.
    >> Share

  698. HONG M, Jung J, Park HS, Lee SM, et al
    Shaofu Zhuyu decoction ameliorates obesity-mediated hepatic steatosis and systemic inflammation by regulating metabolic pathways.
    PLoS One. 2017;12:e0178514.
    >> Share

  699. HO SW, Yeh CB, Yang SF, Yeh HW, et al
    Pneumonia is an independent risk factor for pyogenic liver abscess: A population-based, nested, case-control study.
    PLoS One. 2017;12:e0178571.
    >> Share

  700. LI Z, Lin B, Lin G, Wu Y, et al
    Circulating FGF19 closely correlates with bile acid synthesis and cholestasis in patients with primary biliary cirrhosis.
    PLoS One. 2017;12:e0178580.
    >> Share

  701. MASARONE M, Rosato V, Aglitti A, Bucci T, et al
    Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage.
    PLoS One. 2017;12:e0178473.
    >> Share

  702. LI M, Chen D, Huang H, Wang J, et al
    Caveolin1 protects against diet induced hepatic lipid accumulation in mice.
    PLoS One. 2017;12:e0178748.
    >> Share

  703. ZHENG H, Zou AE, Saad MA, Wang XQ, et al
    Alcohol-dysregulated microRNAs in hepatitis B virus-related hepatocellular carcinoma.
    PLoS One. 2017;12:e0178547.
    >> Share

  704. OHNO Y, Koizumi M, Nakayama H, Watanabe T, et al
    Downregulation of ANP32B exerts anti-apoptotic effects in hepatocellular carcinoma.
    PLoS One. 2017;12:e0177343.
    >> Share

  705. HAGA Y, Kanda T, Nakamura M, Nakamoto S, et al
    Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines.
    PLoS One. 2017;12:e0174153.
    >> Share

  706. JIA J, Qiao Y, Pilo MG, Cigliano A, et al
    Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade.
    PLoS One. 2017;12:e0184068.
    >> Share

  707. HOU W, Gupta S, Beauchamp MC, Yuan L, et al
    Non-alcoholic fatty liver disease in mice with heterozygous mutation in TMED2.
    PLoS One. 2017;12:e0182995.
    >> Share

  708. MATSUSHITA N, Hassanein MT, Martinez-Clemente M, Lazaro R, et al
    Gender difference in NASH susceptibility: Roles of hepatocyte Ikkbeta and Sult1e1.
    PLoS One. 2017;12:e0181052.
    >> Share

  709. CRUZ-BAQUERO A, Cardenas Jaramillo LM, Gutierrez-Meza M, Jarillo-Luna RA, et al
    Different behavior of myeloperoxidase in two rodent amoebic liver abscess models.
    PLoS One. 2017;12:e0182480.
    >> Share

  710. RODRIGUEZ K, Srivaths PR, Tal L, Watson MN, et al
    Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure.
    PLoS One. 2017;12:e0182134.
    >> Share

  711. PINTER M, Haupt L, Hucke F, Bota S, et al
    The impact of thyroid hormones on patients with hepatocellular carcinoma.
    PLoS One. 2017;12:e0181878.
    >> Share

  712. XIMENEZ C, Gonzalez E, Nieves M, Magana U, et al
    Differential expression of pathogenic genes of Entamoeba histolytica vs E. dispar in a model of infection using human liver tissue explants.
    PLoS One. 2017;12:e0181962.
    >> Share

  713. ZHANG Y, Kim DK, Lu Y, Jung YS, et al
    Orphan nuclear receptor ERRgamma is a key regulator of human fibrinogen gene expression.
    PLoS One. 2017;12:e0182141.
    >> Share

  714. DUCHEIX S, Montagner A, Polizzi A, Lasserre F, et al
    Dietary oleic acid regulates hepatic lipogenesis through a liver X receptor-dependent signaling.
    PLoS One. 2017;12:e0181393.
    >> Share

  715. GASLJEVIC G, Edhemovic I, Cemazar M, Brecelj E, et al
    Histopathological findings in colorectal liver metastases after electrochemotherapy.
    PLoS One. 2017;12:e0180709.
    >> Share

  716. KIM J, Lee DY, Park SE, Park CY, et al
    Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation.
    PLoS One. 2017;12:e0180118.
    >> Share

  717. YU J, Yang X, Luo Y, Yang X, et al
    Adverse effects of chronic exposure to nonylphenol on non-alcoholic fatty liver disease in male rats.
    PLoS One. 2017;12:e0180218.
    >> Share

  718. SCHOEMAKER MH, Kleemann R, Morrison MC, Verheij J, et al
    A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice.
    PLoS One. 2017;12:e0180648.
    >> Share

  719. KONG E, Chun KA, Cho IH
    Quantitative assessment of simultaneous F-18 FDG PET/MRI in patients with various types of hepatic tumors: Correlation between glucose metabolism and apparent diffusion coefficient.
    PLoS One. 2017;12:e0180184.
    >> Share

  720. HO SY, Liu PH, Hsu CY, Hsia CY, et al
    Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
    PLoS One. 2017;12:e0180408.
    >> Share

  721. YEN CH, Wang KT, Lee PY, Liu CC, et al
    Gender-differences in the associations between circulating creatine kinase, blood pressure, body mass and non-alcoholic fatty liver disease in asymptomatic asians.
    PLoS One. 2017;12:e0179898.
    >> Share

  722. PRESTIGIACOMO V, Weston A, Messner S, Lampart F, et al
    Pro-fibrotic compounds induce stellate cell activation, ECM-remodelling and Nrf2 activation in a human 3D-multicellular model of liver fibrosis.
    PLoS One. 2017;12:e0179995.
    >> Share

  723. KANAMORI H, Nakade Y, Yamauchi T, Sakamoto K, et al
    Influence of nicotine on choline-deficient, L-amino acid-defined diet-induced non-alcoholic steatohepatitis in rats.
    PLoS One. 2017;12:e0180475.
    >> Share

  724. BAE JS, Kim JH, Yu MH, Lee DH, et al
    Diagnostic accuracy of gadoxetic acid-enhanced MR for small hypervascular hepatocellular carcinoma and the concordance rate of Liver Imaging Reporting and Data System (LI-RADS).
    PLoS One. 2017;12:e0178495.
    >> Share

  725. ZENG T, Wang D, Chen J, Tian Y, et al
    LncRNA-AF113014 promotes the expression of Egr2 by interaction with miR-20a to inhibit proliferation of hepatocellular carcinoma cells.
    PLoS One. 2017;12:e0177843.
    >> Share

  726. YANG YJ, Bang CS, Shin SP, Baik GH, et al
    Clinical impact of non-alcoholic fatty liver disease on the occurrence of colorectal neoplasm: Propensity score matching analysis.
    PLoS One. 2017;12:e0182014.
    >> Share

  727. CHAN SL, Chua APG, Aminkeng F, Chee CBE, et al
    Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients.
    PLoS One. 2017;12:e0186200.
    >> Share

  728. DING L, Wo L, Du Z, Tang L, et al
    Danshen protects against early-stage alcoholic liver disease in mice via inducing PPARalpha activation and subsequent 4-HNE degradation.
    PLoS One. 2017;12:e0186357.
    >> Share

  729. CICALESE L, Curcuru G, Montalbano M, Shirafkan A, et al
    Hazardous air pollutants and primary liver cancer in Texas.
    PLoS One. 2017;12:e0185610.
    >> Share

  730. THEIN HH, Qiao Y, Zaheen A, Jembere N, et al
    Cost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world setting.
    PLoS One. 2017;12:e0185198.
    >> Share

  731. KHAN MAH, Ullah R, Rehman A, Rehman L, et al
    Immunolocalization and immunodetection of the excretory/secretory (ES) antigens of Fasciola gigantica.
    PLoS One. 2017;12:e0185870.
    >> Share

  732. YEH ML, Huang CI, Huang CF, Hsieh MY, et al
    The impact of an additional extra-hepatic primary malignancy on the outcomes of patients with hepatocellular carcinoma.
    PLoS One. 2017;12:e0184878.
    >> Share

  733. AREVALO-HERRERA M, Rengifo L, Lopez-Perez M, Arce-Plata MI, et al
    Complicated malaria in children and adults from three settings of the Colombian Pacific Coast: A prospective study.
    PLoS One. 2017;12:e0185435.
    >> Share

  734. CHEN CT, Liu CY, Yu YB, Liu CJ, et al
    Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients.
    PLoS One. 2017;12:e0185210.
    >> Share

  735. KATSANOS K, Kitrou P, Spiliopoulos S, Maroulis I, et al
    Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials.
    PLoS One. 2017;12:e0184597.
    >> Share

  736. LAMBERT A, Jarlier M, Gourgou Bourgade S, Conroy T, et al
    Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ ACCORD 11 randomized trial.
    PLoS One. 2017;12:e0183288.
    >> Share

  737. PUENGEL T, Krenkel O, Kohlhepp M, Lefebvre E, et al
    Differential impact of the dual CCR2/CCR5 inhibitor cenicriviroc on migration of monocyte and lymphocyte subsets in acute liver injury.
    PLoS One. 2017;12:e0184694.
    >> Share

  738. GUO H, Wu T, Lu Q, Dong J, et al
    Hepatocellular carcinoma in elderly: Clinical characteristics, treatments and outcomes compared with younger adults.
    PLoS One. 2017;12:e0184160.
    >> Share

  739. WAN X, Liu Y, Zhao Y, Sun X, et al
    Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1alpha-dependent and -independent mechanism.
    PLoS One. 2017;12:e0184213.
    >> Share

  740. LIU H, Zhang C, Fan X, Duan Y, et al
    Robust phase-retrieval-based X-ray tomography for morphological assessment of early hepatic echinococcosis infection in rats.
    PLoS One. 2017;12:e0183396.
    >> Share

  741. NIER A, Engstler AJ, Maier IB, Bergheim I, et al
    Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children.
    PLoS One. 2017;12:e0183282.
    >> Share

  742. TSUDA T, Kaibori M, Hishikawa H, Nakatake R, et al
    Near-infrared fluorescence imaging and photodynamic therapy with indocyanine green lactosome has antineoplastic effects for hepatocellular carcinoma.
    PLoS One. 2017;12:e0183527.
    >> Share

  743. LEE JY, Shin DW, Oh JW, Kim W, et al
    Non-alcoholic fatty liver disease as a risk factor for female sexual dysfunction in premenopausal women.
    PLoS One. 2017;12:e0182708.
    >> Share

  744. ALSHAREEDA AT, Sakaguchi K, Abumaree M, Mohd Zin NK, et al
    The potential of cell sheet technique on the development of hepatocellular carcinoma in rat models.
    PLoS One. 2017;12:e0184004.
    >> Share

  745. KURUVILLA SP, Tiruchinapally G, Crouch AC, ElSayed MEH, et al
    Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model.
    PLoS One. 2017;12:e0181944.
    >> Share

  746. KULKARNI S, Dolezal JM, Wang H, Jackson L, et al
    Ribosomopathy-like properties of murine and human cancers.
    PLoS One. 2017;12:e0182705.
    >> Share

  747. WANG L, Feng Y, Ma X, Wang G, et al
    Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis.
    PLoS One. 2017;12:e0182969.
    >> Share

  748. DING S, Jiang J, Zhang G, Bu Y, et al
    Resveratrol and caloric restriction prevent hepatic steatosis by regulating SIRT1-autophagy pathway and alleviating endoplasmic reticulum stress in high-fat diet-fed rats.
    PLoS One. 2017;12:e0183541.
    >> Share

  749. MA Z, Zhang Y, Li Q, Xu M, et al
    Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1alpha expression and mitochondrial ROS production.
    PLoS One. 2017;12:e0183426.
    >> Share

  750. DONAIRES FS, Scatena NF, Alves-Paiva RM, Podlevsky JD, et al
    Telomere biology and telomerase mutations in cirrhotic patients with hepatocellular carcinoma.
    PLoS One. 2017;12:e0183287.
    >> Share

  751. JUN BG, Park WY, Park EJ, Jang JY, et al
    A prospective comparative assessment of the accuracy of the FibroScan in evaluating liver steatosis.
    PLoS One. 2017;12:e0182784.
    >> Share

  752. LI J, Ghazwani M, Liu K, Huang Y, et al
    Regulation of hepatic stellate cell proliferation and activation by glutamine metabolism.
    PLoS One. 2017;12:e0182679.
    >> Share

  753. JIAO Y, Ding L, Chu M, Wang T, et al
    Effects of cancer-testis antigen, TFDP3, on cell cycle regulation and its mechanism in L-02 and HepG2 cell lines in vitro.
    PLoS One. 2017;12:e0182781.
    >> Share

  754. CHOI YR, Kim JH, Park SJ, Hur BY, et al
    Therapeutic response assessment using 3D ultrasound for hepatic metastasis from colorectal cancer: Application of a personalized, 3D-printed tumor model using CT images.
    PLoS One. 2017;12:e0182596.
    >> Share

  755. GARCIA-GARCIA R, Cruz-Gomez AJ, Mangas-Losada A, Urios A, et al
    Reduced resting state connectivity and gray matter volume correlate with cognitive impairment in minimal hepatic encephalopathy.
    PLoS One. 2017;12:e0186463.
    >> Share

  756. BHAT M, Tazari M, Sebastiani G
    Performance of transient elastography and serum fibrosis biomarkers for non-invasive evaluation of recurrent fibrosis after liver transplantation: A meta-analysis.
    PLoS One. 2017;12:e0185192.
    >> Share

  757. DONG J, Zhai B, Sun W, Hu F, et al
    Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells.
    PLoS One. 2017;12:e0185088.
    >> Share

  758. TUDORANCEA I, Porumb V, Trandabat A, Neaga D, et al
    New experimental model for single liver lobe hyperthermia in small animals using non-directional microwaves.
    PLoS One. 2017;12:e0184810.
    >> Share

  759. LUNDGREN H, Martinsson K, Cederbrant K, Jirholt J, et al
    HLA-DR7 and HLA-DQ2: Transgenic mouse strains tested as a model system for ximelagatran hepatotoxicity.
    PLoS One. 2017;12:e0184744.
    >> Share

  760. WEISS TS, Lupke M, Ibrahim S, Buechler C, et al
    Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways.
    PLoS One. 2017;12:e0184282.
    >> Share

  761. KIM AY, Frantz S, Krishnan P, DeMulder D, et al
    Short-term imaging response after drug-eluting embolic trans-arterial chemoembolization delivered with the Surefire Infusion System(R) for the treatment of hepatocellular carcinoma.
    PLoS One. 2017;12:e0183861.
    >> Share

  762. RATNASARI N, Nurdjanah S, Sadewa AH, Hakimi M, et al
    Difference of polymorphism VEGF-gene rs699947 in Indonesian chronic liver disease population.
    PLoS One. 2017;12:e0183503.
    >> Share

  763. MARTINELLI I, Ponziani FR, Maino A, Bhoori S, et al
    Thrombosis after liver transplantation for hepatocellular carcinoma.
    PLoS One. 2017;12:e0186699.
    >> Share

  764. FRIEDRICH-RUST M, Schoelzel F, Maier S, Seeger F, et al
    Severity of coronary artery disease is associated with non-alcoholic fatty liver dis-ease: A single-blinded prospective mono-center study.
    PLoS One. 2017;12:e0186720.
    >> Share

  765. HUBER W, Gruber A, Eckmann M, Elkmann F, et al
    Comparison of pulmonary vascular permeability index PVPI and global ejection fraction GEF derived from jugular and femoral indicator injection using the PiCCO-2 device: A prospective observational study.
    PLoS One. 2017;12:e0178372.
    >> Share

  766. ALCALA M, Calderon-Dominguez M, Serra D, Herrero L, et al
    Short-term vitamin E treatment impairs reactive oxygen species signaling required for adipose tissue expansion, resulting in fatty liver and insulin resistance in obese mice.
    PLoS One. 2017;12:e0186579.
    >> Share

  767. MANCINI M, Salomone Megna A, Ragucci M, De Luca M, et al
    Reproducibility of shear wave elastography (SWE) in patients with chronic liver disease.
    PLoS One. 2017;12:e0185391.
    >> Share

  768. LAURIDSEN MM, Mikkelsen S, Svensson T, Holm J, et al
    The continuous reaction time test for minimal hepatic encephalopathy validated by a randomized controlled multi-modal intervention-A pilot study.
    PLoS One. 2017;12:e0185412.
    >> Share

  769. CHANG JY, Kim SE, Kim TH, Woo SY, et al
    Emergence of rifampin-resistant staphylococci after rifaximin administration in cirrhotic patients.
    PLoS One. 2017;12:e0186120.
    >> Share

  770. MANTOVANI A, Rigolon R, Pichiri I, Bonapace S, et al
    Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus.
    PLoS One. 2017;12:e0185459.
    >> Share

  771. LIU D, Hu Y, Guo Y, Zhu Z, et al
    Mycoplasma-associated multidrug resistance of hepatocarcinoma cells requires the interaction of P37 and Annexin A2.
    PLoS One. 2017;12:e0184578.
    >> Share

  772. MORUZZI S, Guarini P, Udali S, Ruzzenente A, et al
    One-carbon genetic variants and the role of MTHFD1 1958G>A in liver and colon cancer risk according to global DNA methylation.
    PLoS One. 2017;12:e0185792.
    >> Share

  773. DAI D, Wen F, Zhou S, Su Z, et al
    Association of MTTP gene variants with pediatric NAFLD: A candidate-gene-based analysis of single nucleotide variations in obese children.
    PLoS One. 2017;12:e0185396.
    >> Share

  774. SULTAN M, Ben-Ari Z, Masoud R, Pappo O, et al
    Interleukin-1alpha and Interleukin-1beta play a central role in the pathogenesis of fulminant hepatic failure in mice.
    PLoS One. 2017;12:e0184084.
    >> Share

  775. MAO L, Wang Y, Wang D, Han G, et al
    TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
    PLoS One. 2017;12:e0183880.
    >> Share

  776. YE Y, Li Z, Feng Q, Chen Z, et al
    Downregulation of microRNA-145 may contribute to liver fibrosis in biliary atresia by targeting ADD3.
    PLoS One. 2017;12:e0180896.
    >> Share

  777. YOKOTA T, Omachi K, Suico MA, Kojima H, et al
    Bromide supplementation exacerbated the renal dysfunction, injury and fibrosis in a mouse model of Alport syndrome.
    PLoS One. 2017;12:e0183959.
    >> Share

  778. PIERCE AA, Duwaerts CC, Siao K, Mattis AN, et al
    CD18 deficiency improves liver injury in the MCD model of steatohepatitis.
    PLoS One. 2017;12:e0183912.
    >> Share

  779. LEI Y, Wang S, Ren B, Wang J, et al
    CHOP favors endoplasmic reticulum stress-induced apoptosis in hepatocellular carcinoma cells via inhibition of autophagy.
    PLoS One. 2017;12:e0183680.
    >> Share

  780. MUKHERJEE PS, Vishnubhatla S, Amarapurkar DN, Das K, et al
    Etiology and mode of presentation of chronic liver diseases in India: A multi centric study.
    PLoS One. 2017;12:e0187033.
    >> Share

  781. VAN DEN BOSSCHE L, Schoonenberg VAC, Burgener IA, Penning LC, et al
    Aberrant hepatic lipid storage and metabolism in canine portosystemic shunts.
    PLoS One. 2017;12:e0186491.
    >> Share

  782. KIM D, Kim W, Kwak MS, Chung GE, et al
    Inverse association of marijuana use with nonalcoholic fatty liver disease among adults in the United States.
    PLoS One. 2017;12:e0186702.
    >> Share

  783. KIM JH, Kwon HY, Ryu DH, Nam MH, et al
    Inhibition of CUG-binding protein 1 and activation of caspases are critically involved in piperazine derivative BK10007S induced apoptosis in hepatocellular carcinoma cells.
    PLoS One. 2017;12:e0186490.
    >> Share

  784. COEBERGH VAN DEN BRAAK RRJ, Sieuwerts AM, Kandimalla R, Lalmahomed ZS, et al
    High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients.
    PLoS One. 2017;12:e0185607.
    >> Share

  785. KIM S, Chang Y, Sung E, Kim CH, et al
    Non-alcoholic fatty liver disease and the development of nephrolithiasis: A cohort study.
    PLoS One. 2017;12:e0184506.
    >> Share

  786. KIM G, Kang SH, Kim MY, Baik SK, et al
    Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0186990.
    >> Share

  787. AUGUET T, Aragones G, Berlanga A, Martinez S, et al
    Hepcidin in morbidly obese women with non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0187065.
    >> Share

  788. LI S, Takahara T, Fujino M, Fukuhara Y, et al
    Astaxanthin prevents ischemia-reperfusion injury of the steatotic liver in mice.
    PLoS One. 2017;12:e0187810.
    >> Share

  789. RICHTIG G, Aigelsreiter A, Schwarzenbacher D, Ress AL, et al
    SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.
    PLoS One. 2017;12:e0187814.
    >> Share

  790. QIU J, Zhou Z, Wang J, Wang Y, et al
    Associations between fatty liver index and asymptomatic intracranial vertebrobasilar stenosis in Chinese population.
    PLoS One. 2017;12:e0187502.
    >> Share

  791. LEE Y, Kwon DJ, Kim YH, Ra M, et al
    HIMH0021 attenuates ethanol-induced liver injury and steatosis in mice.
    PLoS One. 2017;12:e0185134.
    >> Share

  792. LEE HW, Kim KJ, Jung KS, Chon YE, et al
    The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter.
    PLoS One. 2017;12:e0187066.
    >> Share

  793. XU Y, Li N, Lu M, Dixon E, et al
    The effects of patient cost sharing on inpatient utilization, cost, and outcome.
    PLoS One. 2017;12:e0187096.
    >> Share

  794. KARTOUN U, Corey KE, Simon TG, Zheng H, et al
    The MELD-Plus: A generalizable prediction risk score in cirrhosis.
    PLoS One. 2017;12:e0186301.
    >> Share

  795. MARTINEZ-SERNANDEZ V, Perteguer MJ, Mezo M, Gonzalez-Warleta M, et al
    Fasciola spp: Mapping of the MF6 epitope and antigenic analysis of the MF6p/HDM family of heme-binding proteins.
    PLoS One. 2017;12:e0188520.
    >> Share

  796. PETTA S, Ciresi A, Bianco J, Geraci V, et al
    Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS.
    PLoS One. 2017;12:e0186136.
    >> Share

  797. HSU CY, Liu PH, Ho SY, Huang YH, et al
    Impact of tumor burden on prognostic prediction for patients with terminal stage hepatocellular carcinoma: A nomogram study.
    PLoS One. 2017;12:e0188031.
    >> Share

  798. YATES KP, Deppe R, Comerford M, Masuoka H, et al
    Serum high mobility group box 1 protein levels are not associated with either histological severity or treatment response in children and adults with nonalcoholic fatty liver disease.
    PLoS One. 2017;12:e0185813.
    >> Share

  799. LEE MS, Bae JM, Joo SK, Woo H, et al
    Prospective comparison among transient elastography, supersonic shear imaging, and ARFI imaging for predicting fibrosis in nonalcoholic fatty liver disease.
    PLoS One. 2017;12:e0188321.
    >> Share

  800. PAN JH, Lim Y, Kim JH, Heo W, et al
    Root bark of Ulmus davidiana var. japonica restrains acute alcohol-induced hepatic steatosis onset in mice by inhibiting ROS accumulation.
    PLoS One. 2017;12:e0188381.
    >> Share

  801. PINHEIRO D, Leiros L, Dau JBT, Stumbo AC, et al
    Cytokines, hepatic cell profiling and cell interactions during bone marrow cell therapy for liver fibrosis in cholestatic mice.
    PLoS One. 2017;12:e0187970.
    >> Share

  802. MORELL CM, Fiorotto R, Meroni M, Raizner A, et al
    Notch signaling and progenitor/ductular reaction in steatohepatitis.
    PLoS One. 2017;12:e0187384.
    >> Share

  803. WOO HY, Han SY, Heo J, Kim DU, et al
    Role of endoscopic biliary drainage in advanced hepatocellular carcinoma with jaundice.
    PLoS One. 2017;12:e0187469.
    >> Share

  804. TAN Y, Zhang W, Jiang L, Yang J, et al
    Efficacy and safety of anatomic resection versus nonanatomic resection in patients with hepatocellular carcinoma: A systemic review and meta-analysis.
    PLoS One. 2017;12:e0186930.
    >> Share

  805. ALAZAWI W, Bernabe E, Tai D, Janicki T, et al
    Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0185902.
    >> Share

  806. BACIU C, Pasini E, Angeli M, Schwenger K, et al
    Systematic integrative analysis of gene expression identifies HNF4A as the central gene in pathogenesis of non-alcoholic steatohepatitis.
    PLoS One. 2017;12:e0189223.
    >> Share

  807. FIGORILLI F, Putignano A, Roux O, Houssel-Debry P, et al
    Development of an organ failure score in acute liver failure for transplant selection and identification of patients at high risk of futility.
    PLoS One. 2017;12:e0188151.
    >> Share

  808. ROGAL SS, Udawatta V, Akpan I, Moghe A, et al
    Risk factors for hospitalizations among patients with cirrhosis: A prospective cohort study.
    PLoS One. 2017;12:e0187176.
    >> Share

  809. YANG A, Guo Z, Ren Q, Wu L, et al
    Active immunization in patients transplanted for hepatitis B virus related liver diseases: A prospective study.
    PLoS One. 2017;12:e0188190.
    >> Share

  810. FEIG JL, Mediero A, Corciulo C, Liu H, et al
    The antiviral drug tenofovir, an inhibitor of Pannexin-1-mediated ATP release, prevents liver and skin fibrosis by downregulating adenosine levels in the liver and skin.
    PLoS One. 2017;12:e0188135.
    >> Share

  811. YOO W, Gjuka D, Stevenson HL, Song X, et al
    Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid.
    PLoS One. 2017;12:e0189965.
    >> Share

  812. CEDO L, Santos D, Roglans N, Julve J, et al
    Human hepatic lipase overexpression in mice induces hepatic steatosis and obesity through promoting hepatic lipogenesis and white adipose tissue lipolysis and fatty acid uptake.
    PLoS One. 2017;12:e0189834.
    >> Share

  813. KO Y, Kim J, Park JK, Kim H, et al
    Limited detection of small (</= 10 mm) colorectal liver metastasis at preoperative CT in patients undergoing liver resection.
    PLoS One. 2017;12:e0189797.
    >> Share

  814. ZHENG XY, Zhao X, Yang YF, Jiang HJ, et al
    Antioxidant, antiapoptotic and amino acid balance regulating activities of 1,7-dihydroxy-3,4,8-trimethoxyxanthone against dimethylnitrosamine-induced liver fibrosis.
    PLoS One. 2017;12:e0189344.
    >> Share

  815. HUANG YK, Yen CL, Shiu SI, Lee SW, et al
    Transcatheter arterial chemoembolization after stopping sorafenib therapy for advanced hepatocellular carcinoma.
    PLoS One. 2017;12:e0188999.
    >> Share

  816. RENAULT V, Tost J, Pichon F, Wang-Renault SF, et al
    aCNViewer: Comprehensive genome-wide visualization of absolute copy number and copy neutral variations.
    PLoS One. 2017;12:e0189334.
    >> Share

  817. JEFFERY HC, McDowell P, Lutz P, Wawman RE, et al
    Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score.
    PLoS One. 2017;12:e0188649.
    >> Share

  818. SANDAHL TD, Stoy SH, Laursen TL, Rodgaard-Hansen S, et al
    The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients.
    PLoS One. 2017;12:e0189345.
    >> Share

  819. PARK J, Masaki T, Mezaki Y, Yokoyama H, et al
    Alpha-1 antichymotrypsin is involved in astrocyte injury in concert with arginine-vasopressin during the development of acute hepatic encephalopathy.
    PLoS One. 2017;12:e0189346.
    >> Share

  820. PETA V, Tse C, Perazzo H, Munteanu M, et al
    Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recovery.
    PLoS One. 2017;12:e0189436.
    >> Share

    January 2016
  821. SUN MY, Zhang L, Shi SL, Lin JN, et al
    Associations between Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: A Meta-Analysis.
    PLoS One. 2016;11:e0154337.
    >> Share

  822. MOUZAKI M, Wang AY, Bandsma R, Comelli EM, et al
    Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0151829.
    >> Share

  823. PAN C, Wang X, Shi K, Zheng Y, et al
    MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism.
    PLoS One. 2016;11:e0152090.
    >> Share

  824. ARAGONES G, Auguet T, Berlanga A, Guiu-Jurado E, et al
    Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0154601.
    >> Share

  825. CHIBA T, Suzuki S, Sato Y, Itoh T, et al
    Evaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice.
    PLoS One. 2016;11:e0164191.
    >> Share

  826. EHLKEN H, Wroblewski R, Corpechot C, Arrive L, et al
    Validation of Transient Elastography and Comparison with Spleen Length Measurement for Staging of Fibrosis and Clinical Prognosis in Primary Sclerosing Cholangitis.
    PLoS One. 2016;11:e0164224.
    >> Share

  827. LIU TL, Barritt Iv AS, Weinberger M, Paul JE, et al
    Who Treats Patients with Diabetes and Compensated Cirrhosis.
    PLoS One. 2016;11:e0165574.
    >> Share

  828. BOUTTELL J, Lewsey J, Geue C, Antony G, et al
    The SCottish Alcoholic Liver disease Evaluation: A Population-Level Matched Cohort Study of Hospital-Based Costs, 1991-2011.
    PLoS One. 2016;11:e0162980.
    >> Share

  829. AMARAL KB, Silva TP, Malta KK, Carmo LA, et al
    Natural Schistosoma mansoni Infection in the Wild Reservoir Nectomys squamipes Leads to Excessive Lipid Droplet Accumulation in Hepatocytes in the Absence of Liver Functional Impairment.
    PLoS One. 2016;11:e0166979.
    >> Share

  830. ZHENG S, Zhang P, Chen Y, Zheng S, et al
    Inhibition of Notch Signaling Attenuates Schistosomiasis Hepatic Fibrosis via Blocking Macrophage M2 Polarization.
    PLoS One. 2016;11:e0166808.
    >> Share

  831. HE XX, Wu XL, Chen RP, Chen C, et al
    Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.
    PLoS One. 2016;11:e0162368.
    >> Share

  832. CHENG CW, Liu FC, Lin JR, Tsai YF, et al
    The Impact of Hospital/Surgeon Volume on Acute Renal Failure and Mortality in Liver Transplantation: A Nationwide Cohort Study.
    PLoS One. 2016;11:e0162992.
    >> Share

  833. NOVO-VELEIRO I, Cieza-Borrella C, Pastor I, Chamorro AJ, et al
    A Single Nucleotide Polymorphism in the RASGRF2 Gene Is Associated with Alcoholic Liver Cirrhosis in Men.
    PLoS One. 2016;11:e0168685.
    >> Share

  834. TUTTOLOMONDO A, Di Raimondo D, Bellia C, Clemente G, et al
    Immune-Inflammatory and Metabolic Effects of High Dose Furosemide plus Hypertonic Saline Solution (HSS) Treatment in Cirrhotic Subjects with Refractory Ascites.
    PLoS One. 2016;11:e0165443.
    >> Share

  835. LECUBE A, Valladares S, Lopez-Cano C, Gutierrez L, et al
    The Role of Morbid Obesity in the Promotion of Metabolic Disruptions and Non-Alcoholic Steatohepatitis by Helicobacter Pylori.
    PLoS One. 2016;11:e0166741.
    >> Share